Wantstats
IndustriesCompaniesCharts & Stats
Leads DBAdvisoryPricingContact us
Login
/Company Profiles

Deep Intelligence Across Industries

All CompaniesFortune 500Aerospace & Defense iconAerospace & DefenseAgricultureAutomotive iconAutomotiveFinancial Services iconFinancial ServicesChemicals & Materials iconChemicals & MaterialsConsumer Goods iconConsumer GoodsEnergy & Power iconEnergy & PowerEquipment & Machinery iconEquipment & MachineryFood & Beverages iconFood & BeveragesHealthcare & Pharma iconHealthcare & PharmaInformation Technology iconInformation TechnologyManufacturing & ConstructionMRO iconMROProfessional Services iconProfessional ServicesSemiconductors

Showing 14441 companies

Karin

Karin Technology Holdings Limited

Premium
Information Technology

Karin is a 49-year-old, family-controlled Hong Kong technology distributor and IT solutions integrator. It has transformed from an electronic-components trader into an enterprise IT infrastructure house. In FY2026 the IT Infrastructure segment generated HK$1,870.3 million, or 80% of group revenue of HK$2,334.3 million. The business sells and integrates: - network and cybersecurity - server and storage - data and software - audio-visual IT - increasingly, AI infrastructure It does this for Hong Kong and Macau public- and private-sector customers, sourcing from both Western vendors (Dell, F5, Arista, Oracle, IBM until December 2026) and mainland Chinese vendors (Huawei, xFusion, Zhipu, Huakun, KunLun). Two legacy businesses are in structural decline: **Components Distribution (CD),:** which serves PRC manufacturers. **Others,:** which is consumer electronics retail and distribution under the "In-Smart" brand. The company runs on thin distribution margins: gross margin was 7.8% in FY2026. It has a net-cash balance sheet and a long record of near-100% dividend payouts. Its pivot is towards higher-margin AI solutions, including a dedicated subsidiary (A.II) and two pending agentic-AI and API platform acquisitions. Several things now test that pivot: - an IFRS net loss in FY2026, its first reported annual loss - termination of its IBM distributorship - persistent gross-margin compression --- ### Company's own description In its FY2026 results release (27 August 2026), Karin describes itself as a leading provider of IT solutions and components distribution. It is headquartered in Hong Kong, with offices in Macau and several PRC cities, and is organised into three segments: IT Infrastructure, Components Distribution and Others. **IT Division:** The company calls this its fastest-growing and largest segment. It offers enterprise-grade solutions from global and mainland Chinese vendors across network and cybersecurity, server and storage, data and software applications, audio-video IT, and AI infrastructure, tools and platforms. **CD Division:** The company says this has moved beyond pure distribution into higher-value services such as IC application design, computing solutions and outsourcing. **Others:** This segment covers direct retail through "In-Smart" stores in Hong Kong. Older boilerplate (FY2023 to FY2025 press releases) describes Karin as an electronic and industrial components distributor and IT solutions integrator and outsourcing provider in Hong Kong and the PRC. It traces its expansion into IC application design and data storage management to the 1990s. ### Independent characterisation Economically, Karin is predominantly a value-added reseller, distributor and system integrator (VAR/SI) for enterprise IT in Hong Kong and Macau. Several facts support this: **Project-driven IT revenue:** IT revenue swings with "mega project" wins. It rose 21.1% in FY2024, fell 11.9% in FY2025 and rose 29.9% in FY2026. Management attributes these moves to the timing of large public- and private-sector projects (FY2024 and FY2026 releases). **Low gross margin:** Margins of 7.8% to 9.2% (FY2022 to FY2026) are about double a pure broadline distributor such as VSTECS (4.5% in FY2025). They are well below software or services businesses. This is consistent with a hardware-heavy mix that carries some integration and services value-add. **Hardware-led revenue model with services attached:** The mix between product, service, subscription and licensing is not publicly disclosed. The heavy contract-liability balance suggests meaningful prepaid maintenance and service elements: current unearned revenue was HK$267.2 million at 30 June 2025 (S&P). This is an analyst inference, not a disclosed split. **Vendor concentration:** IBM products sold through subsidiary Compucon contributed up to 15% of FY2025 group revenue (announcement, 14 July 2026). ### Value chain position | Value-chain layer | Karin's role | |---|---| | Vendors (OEMs/ISVs) | Dell Technologies, Huawei, xFusion, IBM (to 31 December 2026), Arista, F5, Oracle, Lenovo ISG, SUSE/Rancher, ZStack, AiShu, DAS-Security, Avaya, Shure, Zhipu, Huakun, BoCloud, LeadSec, KunLun | | Distribution (two-tier) | Compucon, KESCO and Sen Spirit act as distributors to resellers | | Integration and services | Kepro Solutions (Hong Kong, Macau, Australia) and Karin Solutions and Services act as system integrators and professional services providers | | End customers | Hong Kong and Macau government and public bodies, banks and insurers, enterprises, PRC manufacturers (for components), Hong Kong consumers (retail) | ### Customer types and end-markets | Segment | Customer types | End-markets | |---|---|---| | IT Infrastructure | Public sector, financial services, enterprises, resellers | Hong Kong and Macau enterprise IT, cybersecurity, data centre, cloud, AI infrastructure | | Components Distribution | PRC electronics manufacturers and exporters | Communications, computing, electrical appliances, utilities, EVs, robotics (FY2026 outlook) | | Others (consumer electronics) | Hong Kong retail consumers and retailers | Smartphones and accessories (Apple ecosystem), Logitech, Dyson, Beats |

Revenue$0.3B
Employees298
Market CapN/A
Founded1977
Kowloon, Hong Kong

Unlock Verified Contacts

Access verified employee contacts

Decision-maker information to support your sales, lead generation, and business development. 5 users, 5,500 credits a month with rollover, and one credit per contact email.

USD650/mo
Buy Now

Powering the world's best teams.
From next-gen startups to established enterprises.

Google logo
Amazon logo
Microsoft logo
Intel logo
Neste logo
McKinsey & Company logo

What our clients say

Trusted by forward-thinking businesses
for data-driven intelligence

Noah Malgeri
Noah Malgeri

Co-Founder, Mojave Rail Fabrication Limited

This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job.
MR
Michael Robert

Manager, JavolVision

Thanks, I am so happy that we worked together. Maybe we still can work together in the future.
Joseph Aguayo
Joseph Aguayo

Sales Operations & Pricing Manager, Intel

Thanks. It's been a pleasure working with you, please use me as reference with any other Intel employees.
BL
Bong Lau

Sales Leader, Bamberg

We bought your "2025 report" in 2020. Everything is fine and very good.
Peter Groot Koerkamp
Peter Groot Koerkamp

Account and Business Manager, EFS-Holland BV

Thanks for sending the report it gives us a good global view of the Betaïne market.
Younghwan Choi
Younghwan Choi

Senior Retail Manager, LG Chem

We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.
MI
Mark Irwin

Management Consultant, Level 21

I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.
RK
Rob Kooiker

Group Product Manager HVAC & Fire Protection GMA, Rockwool

I have been reading the first document or the study, the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!
JL
Jason Lee

R&D Director, Seojin

Thanks for your great support. Appreciate it. Well received report. It helps us to understand market well. We're planning other area of survey in the future, let's keep in touch.
AM
Akif Moroglu

Strategy & Business Development Director, Dogan Holding

We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.
Wantstats logo

Move faster. Think smarter. Win bigger.

Join our data driven community.

© 2026 All rights reserved by Wantstats Research and Media Pvt Ltd

footer vector

Pages

  • About
  • News
  • Charts & Stats
  • Contact
  • Ecosystem pricing
  • Privacy policy

Address

Wantstats Research and media Pvt. Ltd, Office No 104, Pentagon 4,
Magarpatta City, Pune - 411028,
Maharashtra, India.

Contact

support@wantstats.com

Follow Us

Follow Wantstats on FacebookFollow Wantstats on InstagramFollow Wantstats on LinkedInFollow Wantstats on YouTubeFollow Wantstats on WhatsApp
KansaiPaint

Kansai Paint Co., Ltd.

Premium
Information Technology

Kansai Paint is Japan's second-largest coatings group after Nippon Paint Holdings. PCI Magazine's 2026 Global Top 10 ranks it ninth in the world by 2025 coatings sales. Revenue in FY3/26 was JPY 589.8 bn. The group's historical core is automotive OEM coatings, where it holds leading positions in Japan, India and Indonesia and partners with PPG in North America. Around that core it has built a multi-regional portfolio across industrial, architectural, automotive refinish, marine and protective coatings. Roughly 73% of revenue now comes from outside Japan. The main overseas platforms are: - Kansai Nerolac in India (74.96% owned, listed) - Kansai Helios in Europe (80% owned) - Kansai Altan in Turkey - Kansai Plascon in Sub-Saharan Africa Management's current agenda, the 18th Medium-Term Plan, puts profitability ahead of scale. Its core elements are European restructuring under the "True Color" project, an EBITDA-margin target of 17%, an adjusted ROE target of 15%, and a commitment to return 100% of free cash flow excluding M&A to shareholders. The group is mid-cap, carries moderate leverage, and is exposed to emerging markets. --- ### Company's own description The FY3/26 annual securities report describes the group's main business as manufacturing and selling paints, together with related services. **In Japan,:** the parent company manufactures and sells directly. Affiliates also manufacture, and the parent buys some of their output for resale. Sales go mainly through designated authorized distributors and sales companies, chiefly Kansai Paint Sales Co., Ltd. **Overseas,:** affiliates manufacture and sell mainly within their own countries. **Organization:** the group defines five reportable geographic segments based on its production and sales structure: Japan, India, Europe, Asia and Africa. North America and Mexico sit in "Others" (YUHO-162). The company's mission statement was revised in FY3/26. Its core vision is "making people happy through paint" (塗料で人を幸せにする). The operating philosophy, "ONE KANSAI," runs region-led management where businesses are regional in nature and business-line management where they are global. A common code of conduct, the "KP way," underpins both. The values carried over from the founding are summarized as "Profit and Fairness" (利益と公正). ### Business model and revenue model | Dimension | Characterization | |---|---| | Revenue model | Almost entirely product sales of formulated paints and coatings, recognized at delivery. In Japan, revenue is recognized at shipment where the transit period is normal. | | Licensing income | Kansai licenses technology and trademarks to affiliates in exchange for sales-based royalties. Licensees include Kansai Nerolac (India), Thai Kansai Paint, PPG Kansai Automotive Finishes Technologies LP (USA) and Hunan Xiangjiang Kansai (China). Royalty income is not separately disclosed. | | Services | Color matching and computer color-mixing systems, technical service at OEM paint shops, painter training (e.g., in East Africa) and EHS consulting. Services are embedded in product pricing and not separately reported. | | Subscription | None | | Value chain position | Midstream formulator. Inputs are resins (partly made in-house, e.g., Kansai Resin Thailand), pigments, solvents and additives, largely derived from naphtha and crude oil. Output is sold to OEM lines (auto, industrial), distributors and dealers (architectural, refinish), shipyards (marine) and contractors (protective). | | Customer types | Automotive OEMs and tier-1 suppliers; industrial manufacturers (coil, appliances, machinery, rail, cookware via non-stick coatings, powder-coated goods); professional painters and contractors; retail and DIY consumers (Kanpe Hapio in Japan; Nerolac and Plascon dealer networks); shipbuilders and ship owners; infrastructure owners. | | End markets | Automotive production; industrial manufacturing; residential and commercial construction and repaint; collision repair; shipbuilding and ship maintenance; infrastructure (bridges, steel structures). | ### Revenue mix by end-market | Business field | Revenue FY3/26 | YoY % | Share of group % | |---|---|---|---| | Automotive coatings | 178421 | 0.9 | 30.3 | | Industrial coatings | 176151 | 4.8 | 29.9 | | Architectural (decorative) coatings | 139367 | -3.6 | 23.6 | | Auto refinish, marine and protective | 60328 | -4.5 | 10.2 | | Other | 35525 | -1.2 | 6.0 | | Total | 589795 | 0.2 | 100.0 | ### Independent characterization Kansai Paint is best read as a portfolio of four quite different businesses under one listed parent: 1. **A mature, cash-generative Japanese franchise** (27% of sales, segment margin around 14%). Its value lies in automotive OEM, industrial and marine coatings rather than decorative paint, which is shrinking. 2. **A high-growth but intensely contested Indian decorative and automotive business** run through listed Kansai Nerolac (23–24% of sales). Nerolac's automotive franchise is dominant. Its decorative arm is losing price-mix as new entrants push the market toward lower price points. 3. **A large, low-return European industrial platform** assembled through M&A: Helios in 2017, then Wefa, Beckers' rail business, CWS and Weilburger (27–28% of sales, segment margin around 0–4%). Turkish hyperinflation distorts its reported results, and it is now being restructured. 4. **Smaller but improving emerging-market franchises.** Southeast Asian automotive (high margin, partly held through equity-method affiliates) and Sub-Saharan African decorative paint (rising margins after a blocked 2022 sale). The equity story therefore depends less on top-line growth than on margin repair in Europe, holding share in India, and disciplined capital return.

RevenueN/A
Employees16,739
Market CapN/A
Founded1918
Amagasaki, Japan
Kanoria

Kanoria Chemicals & Industries Ltd.

Premium
Information Technology

Kanoria Chemicals & Industries is a 65-year-old, promoter-controlled Indian manufacturer of formaldehyde-chain "Alco Chemicals": formaldehyde, pentaerythritol (Penta/PE), hexamine, sodium formate, phenolic resins and acetaldehyde. It runs three plants at Ankleshwar (Gujarat), Visakhapatnam and Naidupeta (Andhra Pradesh), with combined formaldehyde capacity of about 1,400 tonnes per day (TPD). The products go mainly into construction, infrastructure, paints and coatings, plywood/laminates, pharmaceuticals and agrochemicals. The company says it leads the Indian market in most of its products, and it is the petitioner behind India's pentaerythritol anti-dumping duties. Through its wholly owned Ethiopian subsidiary, Kanoria Africa Textiles PLC, it also makes integrated denim. In July 2025 it exited a loss-making European automotive-electronics subsidiary (APAG), and it is now repositioning as a focused chemicals company under a "Vision-2030" plan. That plan centres on specialty derivatives (Triacetin, Penta derivatives), resin and formaldehyde capacity, and renewable-energy-led cost reduction. The company is small-cap (about ₹800 Cr market value), BB+-rated, and moderately leveraged. --- ### What the company does KCIL makes commodity and semi-specialty chemical intermediates on a methanol-to-formaldehyde chain. Methanol (bought in) is oxidised to formaldehyde. Formaldehyde is either sold to resin, plywood/laminate and chemical customers, or used captively to make: - **Pentaerythritol (PE / "Penta")**, a polyol for alkyd resins in paints and coatings, plus inks, lubricants and explosives intermediates. Sodium formate is a co-product of the Penta process. **Hexamine:** (hexamethylenetetramine), used in rubber curing, phenolic moulding compounds, pharmaceuticals and fuel tablets. A significant share is exported to Europe and the USA. - **Phenolic resins**, from phenol plus formaldehyde, for foundry, friction, laminates and abrasives. - **Acetaldehyde**, listed in the FY25 MD&A product portfolio. The FY25 MD&A says Penta, hexamine and phenolic-resin process technologies were developed in-house and refined over time for global cost and quality competitiveness. It also says the formaldehyde plants use modern technology that gives cost and quality advantages. The second continuing business is Textiles: an integrated denim mill in Ethiopia run through Kanoria Africa Textiles PLC (KAT), a wholly owned subsidiary. The third, now discontinued, business was Electronics/Automotive. APAG Holding AG (Switzerland) and its subsidiaries in Switzerland, the Czech Republic, Germany (CoSyst Control Systems GmbH) and North America designed and manufactured electronic control units and mechatronic modules for automotive and industrial OEMs. APAG ceased to be a subsidiary with effect from 31 July 2025 and is reported under discontinued operations in FY26. A fourth small activity, a 5 MW solar power plant at Village Bap, Jodhpur (Rajasthan), was sold on a slump-sale basis in FY25 (approved 3 May 2024; buyer SML Electricals India; consideration about ₹8.2 Cr per Reuters). ### Company's own description (paraphrased from the FY25 MD&A) Management describes the Alco Chemicals Division as serving construction, infrastructure, paints, pharma and agrochemicals. Its portfolio is formaldehyde, pentaerythritol, hexamine, sodium formate, phenolic resins and acetaldehyde, made at Ankleshwar, Vizag and Naidupeta. Management claims market leadership in most of these products and a significant presence in the rest. Screener's business summary, drawn from company documents, describes KCI as a maker of chemical intermediates and specialities focused on infrastructure and construction. ### Business and revenue model | Dimension | Characterisation | |---|---| | Revenue model | Almost entirely product sales (B2B bulk/semi-bulk chemicals; denim fabric). No meaningful service, subscription or licensing revenue disclosed | | Pricing | Spot and contract pricing linked to methanol and phenol costs. Margins are spread-driven (product price minus methanol/phenol cost) and exposed to import parity and anti-dumping protection | | Value-chain position | Mid-stream. Buys methanol and phenol (largely import-linked, crude/gas-correlated); sells intermediates to downstream formulators | | Customer types | Paint and coatings makers (Penta), plywood/laminate and resin makers (formaldehyde), foundry and friction-material makers (phenolic resins), rubber and pharma (hexamine), chemical traders. FY23 BRSR lists paint, plywood, chemicals and foundry customers | | End-markets | Construction and real estate, infrastructure, paints, wood panels/furniture, automotive (friction, rubber), pharma, agrochemicals; garment/denim (Ethiopia) | | Capital intensity | Moderate. Standalone net fixed assets about ₹438 Cr against FY26 revenue of ₹875 Cr | | Geographic model | Mainly domestic India sales, plus hexamine exports to Europe and the USA (FY26 Directors' Report) and Ethiopian domestic denim sales | ### Independent characterisation After the APAG exit, KCIL is a single-chain, India-centric formaldehyde derivatives producer with a small African textile appendage. It is cyclical and spread-based. Earnings swing with three things: (a) methanol and phenol prices against Indian demand, (b) the intensity of Chinese, Middle Eastern and Russian dumping, which management cites repeatedly, and (c) trade-remedy protection (Penta anti-dumping duty imposed May 2024). The economics improved in FY26 for four reasons: 1. The loss-making APAG was removed. It had an EBITDA loss of ₹6.6 Cr and a net loss of ₹54.6 Cr in FY25. 2. 345 TPD of new formaldehyde and 18 TPD of new hexamine capacity at Ankleshwar became operational (September 2024). 3. The Penta anti-dumping duty took effect. 4. Ethiopia recovered. Q1FY27 standalone revenue of about ₹430 Cr, roughly half of the whole of FY26 standalone revenue (₹875 Cr), implies a step change. The sources reviewed do not explain it, so the durability of this run-rate is the central analytical question.

Revenue$0.1B
Employees389
Market CapN/A
Founded1960
West Bengal, India
Kam

Kam Hing International Holdings Limited

Premium
Information Technology

Kam Hing International is a Hong Kong-headquartered, family-controlled, vertically integrated knitted-textile manufacturer that has spent three decades supplying dyed knitted fabrics and dyed yarns to garment makers that serve global apparel brands, and which has more recently extended downstream into garment manufacturing. The group operates a "China + Vietnam + Cambodia" production triangle: two textile complexes in Guangdong (Enping and Nansha/Panyu), a recently acquired and expanded textile base in Vietnam's Nhon Trach VI Industrial Zone, and three garment factories in Phnom Penh. With FY2025 revenue of HK$3.69 billion, roughly three-quarters from fabric, it is a mid-tier player in a fragmented, low-margin, tariff-exposed industry. Its customer base is concentrated in Korean, Chinese, Singaporean and Taiwanese garment manufacturers whose end-market is largely the United States. The equity trades at under one-tenth of book value, reflecting a decade of earnings erosion, intermittent losses, and investor scepticism about the return on its South-East Asian diversification. --- ### The company's own description Per the Interim Report 2026 (operating segment note), the group is organised into three reportable segments: (a) the fabric segment, which produces and sells knitted fabric, sells dyed yarns and provides related subcontracting services; (b) the garment segment, which produces and sells garment products and provides related subcontracting services; and (c) an "others" segment that includes sewage treatment services, air and ocean freight handling services and property investment. Management describes the textile business as supported by production bases in China and Vietnam, while the Cambodian factories mainly manufacture garments, together forming a "China+Vietnam+Cambodia" production triangle intended to deliver flexible, integrated solutions for global customers. The FY2024 ESG Report describes Kam Hing as a corporation founded in 1996 primarily focused on the production of assorted fabrics, including knitting, fabric dyeing and fabric finishing, with a downstream garment business. It identifies two textile production plants in China and three garment factories in Phnom Penh, Cambodia. The Enping plant (Guangdong) focuses on fabric knitting, cotton and blends, synthetic long-filament and functional fabric dyeing and printing; the second Guangdong plant handles fabric knitting, cotton fabric dyeing and cotton/blend processing. ### Independent characterization Kam Hing is a contract manufacturer positioned in the middle of the apparel value chain. It buys yarn, knits it into greige fabric, dyes and finishes it (setting, pre-shrinking, printing), and sells finished fabric to "cut-make-trim" garment factories — often located in Korea-, Taiwan- and Singapore-headquartered sourcing groups — that in turn supply international apparel brands and retailers. The garment segment allows it to capture the next step for some customers (fabric-to-garment), largely out of Cambodia. The revenue model is almost entirely product-based (sale of goods), recognised at a point in time on delivery. Subcontracting services (processing customer-owned materials) were a minor 1.0% of revenue in 1H2026 (HK$18.2M of HK$1,774.7M). There is no subscription or licensing revenue. Ancillary utility-type income — sewage treatment fees charged to third parties (HK$20.9M in 1H2026), rental income (HK$3.7M), freight handling fees (HK$3.2M), and sales of electricity, water, steam and scrap — is booked within other income rather than revenue, but it is economically meaningful relative to the group's thin profit. Customer types are B2B: garment manufacturers and sourcing intermediaries. One customer (Customer A) accounted for HK$359.9M, or 20.3% of revenue, in 1H2026 (1H2025: HK$348.2M), and HK$681.8M (17.8%) in FY2024 (FY2023: HK$517.3M, 14.4%); that revenue comes from fabric and dyed yarn sales. The ultimate end-market, per management's FY2024 commentary, "remained" the United States, even though direct invoicing is to Asian intermediaries. End-markets are casual and basic apparel, with growing functional fabric content. ### Revenue model mix | Revenue type (HKD M) | 1H2025 | 1H2026 | |---|---|---| | Sale of goods — fabric | 1425.4 | 1378.9 | | Sale of goods — garment | 390.7 | 377.6 | | Subcontracting services — fabric | 7.3 | 0.7 | | Subcontracting services — garment | 19.6 | 17.6 | | Total revenue | 1843.0 | 1774.7 | | Revenue type (HKD M) | FY2023 | FY2024 | |---|---|---| | Sale of goods | 3575.2 | 3776.0 | | Subcontracting services | 29.2 | 48.4 | | Total revenue | 3604.4 | 3824.3 | Source: Interim Report 2026, Note 3. Source: FY2024 Annual Results Announcement, Note 4. ### Value-chain position | Value-chain stage | Kam Hing participation | |---|---| | Yarn spinning | No (purchases yarn) | | Yarn dyeing | Yes (dyed yarn sales within fabric segment) | | Knitting (greige fabric) | Yes — China, Vietnam | | Fabric dyeing, printing, finishing | Yes — China, Vietnam | | Garment cut-make-trim | Yes — Cambodia (garment segment) | | Brand / retail | No | | Captive utilities | Historically yes (co-generation power plant, water supply, sewage treatment in Guangdong); the power plant at the Panyu/Nansha site was shut down in 2025 |

Revenue$0.5B
Employees6,989
Market Cap$0.0B
Founded1996
P.O. Box, Cayman Islands
Kaisun

Kaisun Holdings Limited

Premium
Information Technology

Kaisun Holdings is a micro-cap, Hong Kong-headquartered, Cayman-incorporated holding company. After a decade of diversification into consulting, media, e-sports, trust services and securities trading, it has refocused almost entirely on a single coal value chain in China. More than 95% of FY2025 revenue (HK$931.1m of HK$969.9m) came from the production and sale of long-flame thermal coal. The coal is linked to Xinjiang Turpan Xingliang Mining in the Tuha (Turpan-Hami) coalfield, which holds a 1.2 Mtpa mining permit. The supporting assets are a Shandong railway-sided coal logistics base (Shandong Kailai), a mining-machinery maker (Tengzhou Kaiyuan) and a railway logistics platform at Choir, Mongolia. The group is financially distressed: it has negative equity (–HK$69.6m), net current liabilities of HK$221.1m, defaulted bonds of HK$46.8m and an auditor's disclaimer. It has also come through a regulatory crisis, in which the Exchange issued a "prejudice to investors' interests" statement against its founder-chairman and the board was then fully renewed. It is best viewed as a high-risk, single-asset turnaround story. --- **Company's own description (FY2025 annual results).** The Company describes itself as an investment holding company. Through its subsidiaries, it is principally engaged in three areas: coal mining, consulting and media services, and corporate and investment. In its FY2025 MD&A, management describes a strategic pivot it calls "Focusing on Core Business and Enhancing Operational Efficiency". It states an aim to become a comprehensive enterprise with full service capabilities in coal resource extraction and commodity supply-chain management. **Independent characterisation.** In economic substance, Kaisun is a thinly capitalised coal producer-trader with a small industrial-services tail. Its activities can be mapped to four operating units and one residual unit: 1. **Coal production and sales — Xinjiang.** Xingliang Mining is in Qiquanhu Town, Turpan, Xinjiang, within the Tuha coalfield. It mines long-flame coal, a high-volatile thermal coal used for power generation and as a chemical feedstock. The mining permit, for 1.2 Mtpa capacity, was obtained in Q4 2022. A fire-zone remediation (fire-extinguishing) project began in November 2023 and has run for about 18 months, with key milestones delivered on schedule. Management frames the remediation as laying the foundation for "subsequent official production". This implies that the large coal revenue booked in FY2024–FY2025 may be associated with the remediation and partial extraction phase rather than steady-state permitted production. *This is an analyst inference; the company has not disclosed production volumes or realised prices in the documents reviewed.* 2. **Coal supply-chain management and logistics — Shandong.** Shandong Kailai Energy Logistics provides loading and unloading, warehousing, coal blending and processing, washing and quality upgrading, and transport. It has the right to use a dedicated railway line at Guanqiao Station (Yanzhou Depot, Jinan Railway Bureau). The 110,000 m² base has stable annual handling capacity of about 3 Mt and sits next to several state-owned chemical enterprises. 3. **Mining and metallurgical machinery — Tengzhou Kaiyuan.** It designs and manufactures overhead manned cableway (chairlift-type personnel transport) devices for mines, plus spare parts, installation and after-sales service. It holds 50 sets of mining-product safety mark certificates and gained European-standard certification in 2023. 4. **Cross-border logistics — Choir, Mongolia.** A railway platform of 35,000 m² with 1.8 Mtpa handling capacity on the China–Mongolia–Russia corridor, near Erenhot. It is operated through a contractor, Sainsaikhan Consulting Services LLC. 5. **Residual corporate and investment.** This covers a Hong Kong listed-securities portfolio (fair value HK$13.1m at 31 Dec 2025), plus remaining trust/trustee and event-management revenue. Management states that the former "Kaisun Business Solutions (KBS)" public-relations and trust services were fully divested during 2025. **Revenue model mix, FY2025 (HK$'000, FY2025 announcement, Note 4)** Product sales made up 97.5% of revenue and services 2.5%. The company has no subscription or licensing revenue. Revenue is recognised at a point in time for 98.7% of FY2025 (HK$957.5m) and over time for 1.3% (HK$12.4m). **Value-chain position:** upstream extraction (coal), midstream logistics, blending and washing, and upstream equipment supply to mines. **Customer types:** coal offtakers, typically power and chemical users and traders in the PRC; mining enterprises (for machinery); and cross-border shippers. Customer concentration is high. In FY2025, three coal customers each exceeded 10% of revenue: Customer a (HK$153.1m), Customer b (HK$113.2m) and Customer d (HK$96.3m). Together they account for about 37% of group revenue. **End markets:** PRC thermal power, coal chemicals, mining capital equipment, and China–Mongolia–Russia cross-border freight.

Revenue$0.1B
Employees101
Market CapN/A
Founded2002
P.O. Box, Cayman Islands
KaiserReef

Kaiser Reef Limited

Premium
Information Technology

Kaiser Reef is an Australian junior gold producer that operates two processing hubs in Tier-1 eastern-states jurisdictions. Its flagship is the Henty Gold Mine in western Tasmania: an underground operation with a permitted 300ktpa carbon-in-leach plant and a 199koz ore reserve, acquired from Catalyst Metals in May 2025 for A$31.6M. The second asset is the Maldon Gold Project in Victoria's Bendigo-zone goldfields, with a wholly owned processing plant, the Union Hill and Nuggety mines, and a historic goldfield endowment of roughly 1.7Moz at about 28g/t. The A1 mine near Woods Point is on care and maintenance. The Henty deal turned Kaiser from a sub-scale, loss-making Victorian producer into a profitable roughly 25–32kozpa business. FY2026 revenue rose 331% to A$150.2M and statutory net profit reached A$16.8M. Management guides 32koz for FY2027. Since March 2026 the company has been fully unhedged against spot gold. It is reinvesting Henty's cash flow into reserve growth there and into an exploration-led restart at Maldon. --- ### What the company does Kaiser Reef explores for, mines, processes and sells gold, with silver as a by-product. Its revenue comes almost entirely from selling gold doré and bullion produced at its two processing plants. It also has a small toll-treatment capability at Maldon, and since August 2026 it has a non-binding framework to buy third-party ore for processing at Henty. **Company's own description (paraphrased from the "About Kaiser Reef" boilerplate in 2026 ASX releases).** Kaiser describes itself as a profitable, multi-asset Australian gold producer with operations in Tasmania and Victoria. It says it is focused on disciplined production growth, reserve expansion, and using its dual processing infrastructure in Tier-1 Australian jurisdictions to generate sustainable cash flow and long-term value. In Tasmania it owns and operates Henty (underground mine, conventional 300ktpa processing plant, targeted production of about 30koz a year). In Victoria it owns, operates and actively explores the Maldon Gold Project. It also owns the A1 Gold Mine, which has been moved to care and maintenance. (Sources: ASX releases of 2 Mar 2026, 10 Apr 2026, 13 Jul 2026 and 10 Aug 2026.) ### Business and revenue model | Revenue stream | Description | Approximate share of revenue | Status | |---|---|---|---| | Gold sales (own production) | Doré from the Henty CIL plant (Tasmania) and the Maldon/Porcupine Flat plant (Victoria), refined and sold at spot | Essentially all revenue | Core | | Silver by-product | Silver poured with Henty doré (6,526oz in the Dec Q 2025; 5,366oz in the Jun Q 2026) | Minor; not separately disclosed | Ongoing | | Toll treatment | Maldon toll-treatment and gravity circuit commissioned (date c. FY2025; see Section 3) | Not separately disclosed | Opportunistic | | Third-party ore purchase | Non-binding Ore Purchase Agreement with Flynn Gold (ASX: FG1), Aug 2026 | Nil to date | Prospective | **Model characterisation.** The business is a pure commodity producer: revenue equals ounces sold multiplied by the realised A$ gold price. There is no subscription, licensing or service element. Since March 2026 all hedging and call-option obligations have been closed out and the company has full spot exposure. Two in-kind obligations remain, both serviced in gold ounces: a gold-loan/prepayment with Auramet International, and deferred payments to Catalyst Metals (ASX releases of 2 Mar 2026 and 10 Apr 2026). ### Value-chain position Kaiser is vertically integrated from exploration through mining and processing to doré production. Refining and marketing are outsourced (the refiner was not identified in this research). It owns both of its processing plants, which is a key strategic feature: Victorian and Tasmanian permitted processing capacity is scarce, and that scarcity is what underpins the Flynn Gold ore-purchase framework and the Maldon JV option granted to Catalyst. ### Customers and end-markets **Direct customers:** bullion refiners and banks, who buy refined gold at spot. Specific counterparties are not publicly disclosed. **End-markets for gold:** investment (bars, coins, ETFs), central-bank reserves, jewellery and technology. These are global and price-setting; Kaiser is a price-taker. **Toll / ore-purchase customers:** junior explorers and small miners in Victoria and western Tasmania (Flynn Gold is the first named counterparty). ### Independent characterisation Kaiser is best understood as a single-mine cash engine (Henty) funding a high-optionality exploration restart (Maldon). Henty produced 25.8koz in FY2026 (sum of reported quarterly Henty production). Its reserve life is more than six years, but its quarterly output is volatile because it depends on remnant stoping and grade control. In the March 2026 quarter, output fell to 5,188oz because of lower-than-expected stoping grades. Maldon is currently a low-output operation processing historical waste-dump stockpiles at about 0.48g/t, with 346–715oz per quarter in FY2026. Its value case rests on finding unmined extensions of the very high-grade Eaglehawk and Nuggety reef systems, now being drilled from new underground development begun in August 2026.

Revenue$0.1B
Employees150
Market CapN/A
Founded2019
Subiaco, Australia
KaisaHealth

Kaisa Health Group Holdings Limited

Premium
Information Technology

Qinghai Biotech Pharmaceutical Group is a Hong Kong-listed, Bermuda-incorporated micro-cap healthcare holding company controlled by distressed property developer Kaisa Group. Its legacy business is mid-to-high-end dental prosthetics and implants under the "Mega" and "Basic" brands, sold mainly in mainland China, with production in Shanghai, Chengdu and the United States. It also runs a small sports-rehabilitation clinic in Shenzhen ("Hejia"). In June 2026 it absorbed a controlling 54.84% stake in Qinghai Pharmaceutical, a state-designated manufacturer of anaesthetic, narcotic and psychotropic active pharmaceutical ingredients (APIs) and finished drugs. That business now generates about 77% of group revenue. The rebranded group says it is building a three-pillar "pharmaceuticals + dental devices + rehabilitation services" ecosystem. The scarce narcotics licences are a genuine strategic asset. They sit alongside a highly leveraged acquired balance sheet carrying bank debt, a RMB600 million-capped third-party financial guarantee linked to Kaisa affiliates, a deficit in shareholders' equity and a disclosed material going-concern uncertainty. --- ### Company's own description (latest filings) In its FY2025 annual results announcement, the company describes itself as an investment holding company whose group is mainly engaged in manufacturing and selling dental prosthetics and implant instruments and providing sport rehabilitation services. The 2026 interim results (25 August 2026) describe three core segments: - pharmaceutical manufacturing; - research, production and sale of dental consumables; - sports rehabilitation medical services. Management says the June 2026 restructuring "formally" established a synergistic layout across these three health industries. The stated aim is to become a listed enterprise providing distinctive and comprehensive medical healthcare services in China, with Qinghai Pharmaceutical as the "core brand" and "Mega" and "Hejia Clinic" as complements. ### Independent characterisation Economically, the group is now a specialty pharmaceutical manufacturer with a sub-scale dental devices business and a negligible clinic business attached. - **Pharmaceutical Business (Qinghai Pharmaceutical, 54.84% owned).** It manufactures anaesthetic and antitussive APIs and finished products, including narcotic and Class I psychotropic drugs, under China's tightly controlled licensing system. The revenue model is product sales (point-in-time recognition) to hospitals, pharmacy chains and pharmaceutical distributors nationwide. One distributor ("Customer A") accounted for HK$61.8 million, or 21.7% of group revenue, in H1 2026. **Dental Business:** It manufactures and sells dental prosthetics (crowns and bridges, removable full and partial dentures, implants, full-cast restorations), digital aesthetic products (veneers, 3D simulated zirconia, clear aligners) and dental implants. Customers are dentists, dental laboratories and technicians, public hospitals (via tenders) and private dental chains in China and overseas. Revenue is 100% product sales, recognised at a point in time. The business has been hurt badly by China's volume-based or centralised procurement (VBP) price ceilings for dental implants and consumables. **Health Care Business (Hejia Rehabilitation):** A single Shenzhen clinic offers post-operative and sports-injury rehabilitation, chronic pain treatment, scoliosis and deformity correction. It is a Shenzhen medical-insurance designated provider. Revenue is service fees, with some prepayment packages booked as contract liabilities. **Financial investments:** The group holds limited-partnership interests carried at fair value through profit or loss (FVTPL): - Zhuhai Jinyiming Equity Investment Fund, 5.51%, cost RMB180 million, held via a VIE structure; - Haoyi Healthcare Services Partnership, 99.9% LP interest, holding the Zhuhai Shili Lianjiang health-leisure/tourism project. Together these were worth HK$151.2 million at 30 June 2026. Before the merger they were the single largest asset class, at 34.4% of total assets at end-2025. ### Revenue model mix | Revenue type | H1 2026 (HK$ M) | Share of revenue | |---|---|---| | Product sales: pharmaceuticals | 219.9 | 77.3% | | Product sales: dental prosthetics and implant instruments | 60.5 | 21.3% | | Services: rehabilitation and health leisure | 4.2 | 1.5% | | Subscription / licensing | 0 | 0% | | Total | 284.6 | 100% | Source: 2026 Interim Results Announcement, Note 4. ### Value-chain position **Pharmaceuticals:** vertically integrated from API synthesis to finished dosage forms, with its own nationwide distribution relationships. It sits upstream of hospitals and distributors in a licensed oligopoly for controlled substances. **Dental:** a mid-stream manufacturer and lab-style producer of custom prosthetics and implant systems. It sells to dental clinics and chains, competes in public-hospital tenders, and depends on dentist and technician relationships. **Rehabilitation:** a downstream direct-to-patient service provider. ### End-markets served 1. China hospital anaesthesia and analgesia (surgical anaesthesia, critical and emergency care, pain management) and antitussives. 2. China dental restoration, aesthetic dentistry and implantology, plus export prosthetics, chiefly to the US. 3. China (Shenzhen) sports-medicine and rehabilitation services.

Revenue$0.0B
Employees1,340
Market CapN/A
Founded1971
Central, Hong Kong
Kaili

Kaili Resources Limited

Premium
Information Technology

Kaili Resources Limited is a Bermuda-incorporated, ASX-listed micro-cap mineral explorer whose only active asset is a 100%-owned, ~1,989 km² rare earth elements (REE) tenement package in the Murray Basin of South Australia. The package comprises EL 6856 Lameroo, EL 6977 Karte and EL 6978 Coodalya, and the company now calls it the "Mallee Project". The company targets ionic-clay-style REE mineralisation in the Loxton/Parilla Sands, the same geological setting in which neighbour Australian Rare Earths (ASX: AR3) has defined a 236 Mt @ 748 ppm TREO JORC resource. Kaili has no revenue, no JORC resource of its own, negative shareholders' equity of A$4.92 million (FY2025), and is funded entirely by interest-free loans from its Chairman. In 2024–2026 it shed its legacy gold, base-metal and nickel-cobalt tenure in Western Australia and the Northern Territory. Control passed in August 2025 from China's Yitai Group to Chairman Jianzhong Yang, and that same month the stock became the subject of one of the most extreme (and ASX-queried) speculative price spikes in ASX history. The investment case is a high-risk, early-stage REE exploration option combined with a pending balance-sheet recapitalisation. --- ### Company's own description AR2025 (Note 1) describes the Group's principal activities as investment in the resources industry and exploration for base and precious metals and rare earth elements. The Directors' Report states that during FY2025 the Group was active in exploration for base and precious metals and rare earth elements. The single operating segment is defined as "the Mining Sector in Australia" (Note 19). The Review of Operations states that the Company focused on REE exploration "considering the high economic potential in development of these critical minerals", after relinquishing tenements of low gold and base-metal potential in 2024 and early 2025. It also says it "continues to seek projects in Australia with potential for copper, gold, silver and base metals." ### Independent characterisation In substance, Kaili Resources is a single-project, greenfield-to-early-stage REE explorer that is related-party-funded. Its activities are: 1. **Tenure management**: holding three granted South Australian exploration licences and meeting their minimum expenditure commitments (A$168,000 due within 12 months of 31 Dec 2025). 2. **Low-cost reconnaissance drilling**: shallow (≤20 m) aircore holes on council road verges. This avoids private-land access negotiations, with samples screened by portable XRF (pXRF) and selected samples assayed by ALS Adelaide (method ME-MS81). 3. **Project generation**: management states it intends to acquire "advanced gold and base metal exploration projects" (AGM presentation, 19 Dec 2025) and "new projects in base and precious metals" (Chairman's Report, AR2025). 4. **Corporate holding activity**: the Group retains dormant subsidiaries from its earlier coal and iron-ore era (APEC Coal Pty Ltd, Kaili Iron Pty Ltd). ### Business model and revenue model | Element | Kaili Resources position | |---|---| | Revenue mix (product / service / subscription / licensing) | Nil revenue in all of FY2021–FY2025. FY2024 "other income" of A$4,911 consisted of tenement rate refunds (A$4,910) and interest (A$1). FY2025 other income: nil | | Monetisation pathway | Defined only in principle: (a) discovery → resource → development or sale; (b) farm-out or sale of tenement interests (cited in the going-concern note as a funding source) | | Value-chain position | Upstream exploration, the earliest stage of the mining value chain. No mining, processing, separation or marketing capability | | Customers | None | | End-markets (prospective) | REE oxides, particularly the magnet rare earths Nd, Pr, Dy and Tb, for permanent magnets in EVs, wind turbines, electronics and defence. AR2024 reported magnet REO averaging ~17% of TREO in the 2024 Lameroo drilling | | Funding model | 100% related-party debt since at least 2021: first Yitai Group (Hongkong) Co., Ltd (A$4.6M), then Chairman Jianzhong Yang and Kaili Holdings Limited (facility of up to A$1.75M). No equity raised in FY2023–FY2025 |

RevenueN/A
Employees81,546
Market CapN/A
Founded1997
Hamilton HM, Bermuda
Kader

Kader Holdings Company Limited

Premium
Information Technology

Kader Holdings is a family-controlled Hong Kong conglomerate built on two very different businesses. The first is a vertically integrated model-train and toy business. Kader owns the Bachmann franchise: Bachmann Industries in the United States, plus Bachmann Branchline, Graham Farish and Liliput in Europe. Its own factories in Dongguan, Mainland China, make these products. It also manufactures plastic, electronic and stuffed toys on an OEM basis for third parties. This business produced 87.5% of FY2025 revenue (HK$307.36M). The second is a Hong Kong-centred investment property portfolio, anchored by the Kader Building in Kowloon Bay. It produced HK$43.80M of rent in FY2025 but holds about 73% of segment assets. The investment case is a classic Hong Kong "asset-rich, earnings-poor" situation. Book NAV is about HK$1.83 per share against a share price near HK$0.19, a discount of roughly 90%. This sits alongside five consecutive years of shareholder losses (FY2022–FY2025), heavy short-term revolving bank debt (HK$719.8M), net current liabilities of HK$386.0M, persistent property revaluation deficits, and no dividend since 2019. --- ### Company's own description (AR2025) **Holding company:** The Company is an investment holding company. **Subsidiaries:** Their principal activities are: - manufacture and trading of plastic, electronic and stuffed toys and model trains; - property investment; - investment holding. **Toys and model trains:** Products are mainly made in the Group's factories in Chinese Mainland and sold mostly to the United States, Europe and Chinese Mainland. **Property investment:** Described as playing "a significant role" alongside the core toys business, with properties in Hong Kong and overseas. **Reporting segments (unchanged since at least FY2021):** - Toys and Model Trains: manufacture and sale of plastic, electronic and stuffed toys and model trains made in Mainland China facilities. - Property Investment: leasing office premises, commercial and industrial buildings for rental income and long-term capital appreciation. - Investment Holding: investment in securities. ### Independent characterisation Kader is best understood as three overlapping businesses. 1. **Branded hobby products (model railways).** - Kader owns well-known hobby brands in each target market. In North America it has Bachmann and Williams by Bachmann. In the UK it has Bachmann Branchline (OO gauge) and Graham Farish (N gauge, 1:148). In continental Europe it has Liliput. - Its strategy, documented in secondary sources, has been to buy a perceived quality brand in each target country and move production to Kader's own Chinese plants. - This is a design-to-retail model: in-house tooling and manufacturing in Dongguan, then wholesale through hobby-shop dealer networks and, increasingly, direct sales via the subsidiaries in the US and UK. - The geographic revenue split supports this. Europe (HK$151.3M) and North America (HK$134.2M) together made up 83% of FY2024 revenue. 2. **OEM/contract toy manufacturing.** Plastic, electronic and stuffed toys are made for third-party brand owners. Aggregators also note mould sales and toy sales agency activity. This is a low-margin, volume-sensitive business exposed to US–China tariff policy and customer concentration. In FY2025 one customer was 11.46% of Group sales (the largest customer was 11% in AR2025's supplier/customer table), and the top five were 25%. 3. **Property investment.** - The flagship is the Kader Building at 22 Kai Cheung Road, Kowloon Bay. It is a former industrial building undergoing revitalisation under the HKSAR industrial-building revitalisation framework. - Further investment properties sit in Hong Kong and overseas, including a Singapore property bought in 2022. - Investment properties were carried at HK$1,915.3M at 31 Dec 2024 and dominate the balance sheet. ### Revenue model mix (FY2021–FY2025) | Revenue type (HK$ M) | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | |---|---|---|---|---|---| | Product sales (toys and model trains, HKFRS 15) | 346.63 | 302.38 | 322.75 | 293.84 | 307.36 | | Rental income (investment properties) | 50.70 | 49.59 | 49.79 | 49.87 | 43.80 | | Total revenue | 397.33 | 351.97 | 372.54 | 343.71 | 351.16 | | Product share of revenue (%) | 87.2 | 85.9 | 86.6 | 85.5 | 87.5 | | Rental share of revenue (%) | 12.8 | 14.1 | 13.4 | 14.5 | 12.5 | Sources: FY2022 and FY2024 results announcements, Note 3; AR2025 MD&A. There is no subscription or licensing revenue line. Royalties appear only as a cost (HK$9.86M in FY2024), which is consistent with licensed character or railway-livery products. ### Value-chain position, customers and end markets **Value-chain position:** - Upstream: tooling and design. - Midstream: injection moulding, electronics and assembly in Dongguan, including Dongguan Feng Da Electronics. - Downstream: branded wholesale distribution through Bachmann subsidiaries in the US and UK/Europe. - Kader therefore captures both factory margin and brand margin on model trains. That is unusual among Hong Kong toy OEMs, which mostly stop at contract manufacturing. **Customer types:** - Hobby retailers and distributors (model railways). - Mass-market toy brand owners and retailers (OEM toys). - Direct consumers through subsidiaries' channels (extent not disclosed). - Commercial and industrial tenants (property). **End markets:** Adult collector and hobbyist model railways in the US, UK and Germany/Austria; children's toys; Hong Kong commercial and industrial leasing.

Revenue$0.0B
Employees588
Market CapN/A
Founded1948
Hamilton HM, Bermuda
K2

K2 Asset Management Holdings Ltd

Premium
Information Technology

K2 Asset Management Holdings is a Melbourne-based, founder-controlled financial services micro-cap. Over the past six years it has turned itself from a performance-driven boutique long/short equity hedge fund manager into a third-party fiduciary and fund-infrastructure provider. Its operating subsidiary uses its Australian Financial Services Licence, governance framework and administration capability to act as Responsible Entity (RE), trustee and administrator for more than 20 external investment managers. This represents about A$4.4 billion of the group's A$4.7 billion AUM at 30 June 2026. Alongside this, it runs a shrinking set of in-house and sub-advised funds, a growing CIO Office/investment advisory business (built around a A$242 million multi-asset mandate), and RE/administration services for ASX-quoted funds. Revenue is about A$6.1 million and is roughly 74% recurring RE/trustee/administration fees. The investment case rests on operating leverage once its FY2026 restructuring is complete, the balance-sheet strength implied by cash of about 56% of market capitalisation, and regulatory tailwinds and pressures in the RE industry. --- ### The company's own description In its FY2026 Annual Report (Directors' Report, "Principal Activities"), K2 describes K2 Asset Management Holdings Ltd as the holding company of K2 Asset Management Ltd, K2 Corporate Services Pty Ltd, KII Pty Ltd and Trusuper Pty Ltd. It states that the principal activity of K2 Asset Management Ltd during the year spanned three "core pillars": 1. Responsible Entity (RE), Trustee & Administration Services; 2. Exchange Traded (ETF) & Listed Fund Services; and 3. Funds Management & Investment Advisory. K2 Corporate Services Pty Ltd provides Fund Investment Advisory Services within the third pillar. The Chair's Report (FY2026) calls the RE, Trustee and Administration division "the cornerstone of K2's operations". Following a strategic review, the Board resolved during FY2026 to "consolidate K2's broader in-house funds management activities" and to focus on RE, Trustee, Administration and Investment Advisory. ### Independent characterisation K2 has become a specialist outsourced fiduciary (RE/trustee) and fund administration provider with an attached multi-manager advisory/OCIO capability. It is no longer a conventional active equity manager. The economics of the business have changed accordingly: **Pre-2020 model (legacy):** K2 managed absolute-return long/short equity funds across Australian, Asian and global equities. Revenue depended on management fees on internal funds under management (FUM) and on volatile performance fees above high-water marks. FUM was A$670 million at the 2007 IPO. Revenue collapsed as performance and FUM declined: FY2022 revenue was A$2.12m and FY2023 revenue was A$1.98m. **Post-2020 model (current):** K2 rents its AFSL, compliance, governance, board oversight, unit registry/administration coordination and RE capabilities to external managers. Fees are charged as a basis-point rate on fund net or gross asset value, usually with a minimum annual RE fee. Establishment fees are charged on new funds, and fixed fees are charged to corporate authorised representatives (CARs). The model has lower margins per dollar of AUM, which is why A$4.7bn of AUM produces only about A$6.1m of revenue (about 13bp blended). However, it is less exposed to investment performance, stickier because switching RE requires a unitholder vote, and scalable on a largely fixed compliance cost base. ### Revenue model mix (FY2026, Annual Report Note 4) | Revenue line (FY2026) | A$ | % of total | Nature | |---|---|---|---| | Administration service fees | 2,141,073 | 34.9% | Recurring service (bp of fund gross assets) | | Responsible entity fees | 1,776,666 | 28.9% | Recurring service (bp of NAV/GAV with minimum) | | Establishment fees | 447,171 | 7.3% | Project / one-off service | | Corporate authorised representative fees | 178,979 | 2.9% | Recurring fixed fee (licensing) | | Investment advisory service fees | 720,795 | 11.7% | Recurring service (bp of advised NAV) | | Management fees (own funds) | 338,943 | 5.5% | Recurring asset-based | | Performance fees (own funds) | 100,681 | 1.6% | Variable / point-in-time | | Interest income | 281,833 | 4.6% | Treasury | | Other income | 156,862 | 2.6% | Other | | Total | 6,143,003 | 100.0% | — | Classified as service versus product versus licensing: about 77% is fiduciary/administration service revenue (including establishment), about 3% is licensing (CAR), about 12% is advisory service, about 7% is traditional fund management (product), and about 7% is interest and other. There is no subscription or software revenue. ### Value chain position K2 sits in the manufacturing-infrastructure layer of the Australian managed funds value chain. Investment managers (asset originators) need a licensed RE to issue registered managed investment schemes to retail investors under Chapter 5C of the Corporations Act, and need a trustee for unregistered wholesale trusts. K2 provides that legal wrapper and governance layer. It also coordinates outsourced custody, unit registry and fund accounting, provides fund administration, and offers distribution-readiness support (PDS issuance and compliance plans). Downstream, its clients' products reach investors through platforms, advisers, SMSFs and the ASX (for quoted funds). ### Customer types and end-markets | Customer segment | Service consumed | Evidence | |---|---|---| | Boutique and emerging investment managers (domestic and offshore) launching Australian funds | RE / trustee / administration / establishment | "Over 20 managers across a diverse range of asset classes" (FY2026 Chair's Report) | | Managers seeking to replace an incumbent RE | RE replacement | 2023 CD Private Equity Funds I–III vote to appoint K2 as RE | | Issuers of ETFs and ASX-quoted funds | RE and listed fund administration | A$226.2m ETF & Listed Fund Services AUM (June 2026) | | Wealth management groups and family offices | CIO Office / investment advisory, SMAs | A$242m mandate from an existing wealth manager (January 2025) | | Corporate authorised representatives | Licensing under K2's AFSL | A$179k CAR fees (FY2026) | | Retail, wholesale and SMSF investors | Legacy K2 funds (K2 Opportunities Fund; Select International Alpha Fund) | Funds Management AUM A$238.3m (June 2026, including advisory) | The end-market is exclusively Australian. The FY2026 Annual Report states that the company operates solely within Australia's financial services industry.

Revenue$0.0B
Employees20
Market CapN/A
Founded1999
Melbourne, Australia
K.

K. Wah International Holdings Limited

Premium
Information Technology

K. Wah International Holdings is the listed property flagship of the Lui family's K. Wah Group, an integrated developer and investor positioned at the premium end of the Hong Kong and Chinese residential markets, with a strategic focus on Hong Kong, the Yangtze River Delta (Shanghai, Nanjing, Suzhou) and the Pearl River Delta (Guangzhou, Dongguan, Jiangmen). Its model combines lumpy, project-driven residential sales — increasingly executed through minority joint ventures with larger Hong Kong developers — with a recurring rental base of roughly 330,000 sq m of attributable investment property anchored by Shanghai K. Wah Centre. A distinctive feature is its 3.71% stake in Galaxy Entertainment Group, worth approximately HK$6.2 billion at end-2025 and roughly equal to KWIH's entire market capitalisation. The company trades at a deep discount (about 0.16x book) reflecting a loss-making FY2025, Mainland impairments and a generational leadership transition following the founder's death in November 2024, offset by conservative leverage (9% net gearing at June 2026). --- ### Company's own description The Annual Report 2025 describes KWIH as the listed property arm of K. Wah Group which, with a strong foothold established in Hong Kong, has grown into an integrated developer and investor of exquisite and niche projects with a strategic focus on Hong Kong, the Yangtze River Delta and the Pearl River Delta. Its portfolio spans large-scale residential communities and comprehensive developments including premium residences, Grade-A office towers, hotels, serviced apartments and retail premises. Cresleigh Property, the group's property-management arm, provides hotel-style serviced property management to residential, commercial, office and mixed-use assets. The stated mission is to focus on customer needs and pursue excellence through research, design and value creation, while providing shareholders with the best return on investment. ### Business model KWIH operates two reportable segments as defined for the chief operating decision-maker (the Board): Property Development (sub-reported for Hong Kong and the Mainland) and Property Investment, plus an Others line containing corporate treasury, hotel operations and administration (FY2024 Annual Results Announcement, Note 2). The economic model has three engines: 1. **Build-to-sell residential development.** The company acquires land (by government tender, MTR property-development tender, urban redevelopment, or JV participation), develops premium residential projects, pre-sells units under consent schemes and recognises revenue at a point in time upon handover. Contracted-but-unrecognised sales therefore act as a forward revenue backlog (HK$5.6 billion attributable at 30 June 2026). 2. **Recurring rental and hospitality income.** A diversified investment portfolio of offices, retail podiums, serviced apartments and hotels generated rental income (including hotel operations) of ~HK$680 million in FY2025 and ~HK$350 million in 1H2026. 3. **Strategic financial investment.** A long-held 162 million-share (3.71%) stake in Galaxy Entertainment Group (GEG), measured at fair value through other comprehensive income, which yields dividend income (HK$195 million in FY2025) and drives large swings in comprehensive income. ### Revenue model mix | Revenue type (HK$ M) | FY2023 | FY2024 | FY2025 | |---|---|---|---| | Sale of properties | 5373.4 | 6453.8 | 1302.4 | | Rental income | 637.2 | 643.0 | 598.4 | | Hotel operations | 92.3 | 90.7 | 84.3 | | Total consolidated revenue | 6102.8 | 7187.4 | 1985.0 | | Property sales share of revenue (%) | 88.0 | 89.8 | 65.6 | | Rental + hotel share of revenue (%) | 12.0 | 10.2 | 34.4 | Source: FY2024 Annual Results Announcement Note 3; Annual Report 2025 MD&A. Shares computed. The model is overwhelmingly product (property sales) with a service-like recurring layer (leasing, hotels, property management). There is no subscription or licensing revenue. ### Consolidated vs. attributable revenue — a critical distinction | Metric (HK$ M) | FY2023 | FY2024 | FY2025 | |---|---|---|---| | Consolidated revenue | 6103 | 7187 | 1985 | | Attributable revenue from JVs and associates | 5857 | 1239 | 9564 | | Total attributable revenue | 11960 | 8426 | 11549 | | JV share of attributable revenue (%) | 49.0 | 14.7 | 82.8 | Because a growing share of the Hong Kong pipeline is held in minority JVs (10%–50% stakes), consolidated revenue materially understates activity. Management reports "attributable revenue" which adds KWIH's share of JV/associate revenue. Source: FY2023 and FY2024 Annual Results Announcements; Annual Report 2025. FY2023 JV contribution computed as 11,960 − 6,103. In FY2025, 83% of attributable revenue came through JVs (KT Marina, Grand Mayfair, Villa Garda), which explains why consolidated revenue collapsed 72% while attributable revenue rose 37%. ### Value-chain position, customers and end-markets KWIH sits at the land-acquisition, design, development-management and sales/marketing end of the real estate value chain; construction is outsourced to contractors who must meet the group's quality, environmental and OHS standards (Annual Report 2025, ESG section). The group retains asset management and property management (Cresleigh) for completed assets. Customer types: (i) individual end-user and upgrader homebuyers in Hong Kong and Tier-1/Tier-2 Mainland cities — the Chairman's Statement 2025 explicitly targets "upgraders"; (ii) multinational corporate office tenants (Shanghai K. Wah Centre); (iii) retail and F&B tenants; (iv) expatriate and high-income residential leasing tenants (Stanford Residences, Chantilly); (v) hotel guests (Crowne Plaza Guangzhou Huadu; Holiday Inn Express Jiangmen). ### Independent characterisation KWIH is best understood as a mid-sized, family-controlled, balance-sheet-conservative developer whose earnings are structurally lumpy and currently in a trough. It lacks the scale of Hong Kong's "big four" developers, so it increasingly participates in large Hong Kong sites as a junior JV partner, ceding control and consolidated revenue in exchange for diversification and access. Its Mainland business, built over two decades in the Yangtze and Pearl River Deltas, has shifted from profit engine (FY2021 peak) to source of impairments as Chinese residential prices corrected. The investment-property book provides a stable floor of ~HK$440–490 million of segment EBITDA annually. The GEG stake is a de facto hidden asset: at end-2025 prices it equated to roughly 98% of KWIH's current market capitalisation, implying the market ascribes near-zero value to the HK$40 billion property-centred book equity.

Revenue$0.3B
Employees732
Market CapN/A
Founded1955
North Point, Hong Kong
K

K W Nelson Interior Design and Contracting Group Limited

Premium
Information Technology

| Field | Detail | Source | |---|---|---| | Legal name | K W Nelson Interior Design and Contracting Group Limited | HKEXnews filings | | Chinese short name / stock short name | K W NELSON GP | HKEX / ET Net | | Former name | K W Nelson Interior Architect Group Limited (changed August 2017) | S&P Global profile; Finnomena | | Founding year (operating business) | 1989 | S&P Global profile | | Incorporation jurisdiction | Cayman Islands (exempted company with limited liability) | HKEX announcements | | Headquarters | Room 1703, 17/F, Technology Plaza, 651 King's Road, Quarry Bay, Hong Kong | ET Net company profile | | Telephone / Fax / Email | +852 2856 9330 / +852 2590 9185 / info@kwnelson.com.hk | ET Net | | Exchange and ticker | GEM, Stock Exchange of Hong Kong; 8411 (8411.HK / 08411) | HKEX | | Listing date and price | 8 December 2016 at HK$0.20 per share | ET Net | | ISIN | KYG5335N1079 (brief's JP3885780001 is incorrect) | S&P Global; SustainabilityReports.com | | CUSIP | Not applicable / not publicly disclosed | — | | Par value | HK$0.01 | ET Net | | Issued share capital (registered) | 1,000,000,000 shares | ET Net | | Shares outstanding (S&P basis, ex-treasury/held) | 950.40 million (FY2025); 939.62 million (Jun 2026 filing basis) | S&P Global | | Fiscal year end | 31 December | HKEX filings | | Employees (latest) | 14 | S&P Global profile (2026) | | Employee trend (3-year) | Not publicly disclosed in sources reviewed | — | | Auditor | Linksfield CPA Limited | ET Net company profile | | Principal banker | Bank of China (Hong Kong) | ET Net | | Legal advisers | Loeb & Loeb LLP; Dentons; Conyers Dill & Pearman (Cayman) | ET Net | | Share registrar (HK) | Tricor Investor Services Limited | ET Net | | Controlling shareholder | Mr. Lau King Wai — 750,000,000 shares (75.00%) as at 30 June 2025 | ET Net | | Share price (latest observed) | HK$0.118 (8 October 2026) | StockAnalysis.com | | Market capitalisation (derived) | c. HK$112 million (HK$0.118 × 950.4m shares) | Derived | | Enterprise value (derived) | c. HK$81 million (market cap less HK$31.6m net cash at 30 Jun 2026) | Derived | | Website | http://www.kwnelson.com.hk | Company | K W Nelson is a founder-controlled Hong Kong interior design-and-build contractor, established in 1989 and listed on GEM since December 2016, that delivers turnkey commercial interiors: pre-lease advisory, space planning, interior design, project management, fitting-out construction and after-sales maintenance. Historically focused on office and retail premises, the group diversified into medical centres and elderly care homes and, most recently, data-centre and IT-solution-adjacent fit-out work. After four consecutive loss-making years (FY2021–FY2024) as revenue contracted from HK$82 million to HK$22 million, the company returned to profit in FY2025 on a 127% revenue rebound driven by office and data-centre projects, and its first half of 2026 confirmed the recovery. With a 75% controlling shareholder, a lean 14-person team, an unlevered, cash-rich balance sheet and a demonstrated willingness to return surplus capital through large special dividends, K W Nelson is best characterised as a cyclical, project-lumpy micro-cap with a strong net-cash floor. --- ### The company's own description In its regulatory filings and as summarised by S&P Global Market Intelligence, the group describes itself as an investment holding company whose subsidiaries act as an interior decorator for commercial premises in Hong Kong. Its stated service chain spans pre-lease advisory, interior design, space planning, project management, construction and fitting-out works, after-sales services, and "life-time maintenance" for tailor-made sections. Its most recent profile (S&P, updated July 2026) adds IT solution services and lists the clientele as offices and data centres, elderly homes, medical centres, galleries and residential premises. Earlier descriptions (2017–2023) emphasised offices and retail stores, restaurants and shopping malls. The single reportable segment, as disclosed in results and noted by Simply Wall St, is the provision of interior designs, project management services and fitting-out works. ### Independent characterisation K W Nelson is, economically, a small design-and-build (D&B) fit-out contractor occupying the interface between corporate occupiers (tenants) and the trade subcontractor base. Its value proposition is single-point responsibility: one firm handles the occupier's journey from pre-lease space evaluation through design, permitting coordination, procurement, construction management and post-handover maintenance. Unlike a pure interior design consultancy, it takes construction risk and recognises the full contract value (including subcontracted trade costs) as revenue; unlike a general building contractor, it operates at the tenant-improvement scale (individual floors, clinics, care homes, server/IT rooms) rather than shell-and-core construction. The business has three economically important characteristics: 1. **Project lumpiness.** With revenue of HK$21.5m–HK$48.8m in recent years, a handful of contracts determine each year's result. Revenue swung -46% (FY2021), -4% (FY2022), -32% (FY2023), -25% (FY2024) and +127% (FY2025) (S&P Global, FY2021–FY2025). 2. **High operating leverage on a fixed overhead base.** SG&A has been sticky at HK$12.4m–HK$16.2m per year (S&P Global). Gross profit below roughly HK$13–14m produces losses; above that level, profit expands quickly — as the 1H2026 swing demonstrates. 3. **Asset-light, cash-rich balance sheet.** Property, plant and equipment is only HK$1.64m (FY2025), there is no bank debt (debt consists solely of lease liabilities of c. HK$1m), and cash plus short-term investments were HK$40.75m at end-FY2025 (S&P Global). ### Revenue model | Revenue type | Share of revenue | Comment | |---|---|---| | Project-based design & fit-out contracts (design + construction, recognised over time) | Substantially all | Single reportable segment per filings | | Pre-lease advisory / design-only fees | Not separately disclosed | Bundled into project revenue | | After-sales and maintenance services | Not separately disclosed | Small; recurring element | | IT solution services | Not separately disclosed | Newly referenced in 2025–2026 profile; scale unknown | | Subscription / licensing | None | Not applicable | ### Value chain position | Value chain stage | K W Nelson role | |---|---| | Occupier site search and lease evaluation | Pre-lease advisory (front-end, relationship-building) | | Space planning and interior design | In-house design team led by Design Director Leung May Yan | | Approvals and coordination | Project management | | Procurement of materials, FF&E | Managed by group; supplied by third parties | | Trade works (carpentry, M&E, finishes) | Largely subcontracted (inferred from cost-of-sales structure and 14-person headcount) | | Handover, defects, maintenance | After-sales and life-time maintenance services | ### Customer types and end-markets | End-market | Evidence and trend | Source | |---|---|---| | Corporate offices | Core historic market; driver of FY2023 partial offset and FY2025 rebound | Glonghui (FY2023 results); Tiger Brokers (FY2025 results) | | Data centres / IT rooms | Newly cited driver of FY2025 growth | Tiger Brokers summary of FY2025 results (19 Mar 2026) | | Medical centres | Material in FY2022; declined in FY2023 | Glonghui (FY2023 results) | | Elderly / residential care homes | Material in FY2022; declined in FY2023 | Glonghui (FY2023 results) | | Retail, restaurants, shopping malls | Cited in earlier descriptions; de-emphasised in recent profile | Finnomena profile; ACN Newswire (2018) | | Galleries, residential premises | Listed in current profile | S&P Global profile | Given revenue scale, concentration is almost certainly high.

Revenue$0.0B
Employees14
Market CapN/A
Founded1989
Quarry Bay, Hong Kong
K&S

K&S Corporation Limited

Premium
Information Technology

K&S Corporation is a mid-cap, family-controlled Australasian transport and logistics group. It has one of the deepest commodity-haulage franchises in Australia, and in its FY2025 Annual Report it describes itself as the country's leading carrier of steel products and a major carrier of sawn timber. The group runs three reportable segments: **Australian Transport:** road linehaul, rail intermodal, contract logistics, bulk, chemical and fuel cartage, WA heavy haulage and aviation refuelling. **Fuels:** a South Australian fuel retailing and wholesaling business that dates back to an Ampol agency opened in 1954. **New Zealand Transport:** Revenue is about A$729M (FY2026), with roughly 1,500 staff and a freehold industrial property portfolio carried at A$353M. The board's stated strategy is to improve the quality of its revenue base rather than chase top-line growth. The group is conservatively geared, at 12.8% excluding leases. Its earnings are cyclical and heavily exposed to construction activity. It lost its decades-long InfraBuild steel-haulage work in FY2026, which is its most significant customer loss in recent history. --- **Company's own description.** The FY2025 Annual Report sets out the company's vision as being the leading provider of transport and logistics solutions in its target markets of Australia and New Zealand. It lists the principal activities as transport and logistics, warehousing and fuel distribution. In its Operating and Financial Review, the company calls itself a tier-one logistics provider that specialises in tailored logistics solutions. It says its success rests on continuous improvement in safety, service and employee engagement. **Business model.** K&S is an asset-heavy operator. It owns: - its prime-mover and trailer fleet (about A$421M spent on fleet upgrades over the past decade, per the FY2025 AR); - workshops embedded in its depots (13 of them); - a large freehold terminal network (carrying value A$353.1M at 30 June 2026). It supplements its own fleet with subcontractors, managed through its KasSub compliance portal. Contractor expenses were A$143.0M in FY2025, down from A$181.3M in FY2024, according to the FY2025 income statement. **Revenue model.** The model has no meaningful subscription or licensing component. A rough split between product and service can be inferred from the FY2025 line "consumption of fuel held for sale", which was A$151.1M. That suggests fuel sales account for something like 20–25% of operating revenue, with the rest coming from services. This split is derived and not disclosed by the company. **Value-chain position.** K&S sits in the middle of the freight value chain. It runs: - line-haul road freight; - rail freight forwarding, buying linehaul capacity from Pacific National under a core agreement renewed in FY2025; - intermodal terminals and container handling (Coopers Plains in Brisbane, and the new Gillman terminal in Adelaide); - contract logistics and warehousing (DTM); - specialised bulk, dangerous goods and chemical cartage (Chemtrans, Bulktrans); - fuel cartage (K&S Energy); - heavy haulage (WA); - aviation refuelling (Aero Refuellers). In fuels it is a downstream reseller and retailer in South-East South Australia. **Customer types and end-markets.** K&S serves: - steel producers and distributors (historically its anchor market: OneSteel, then Smorgon, then InfraBuild); - timber and forestry; - construction materials; - energy and fuel majors; - chemicals; - FMCG and manufacturing; - mining and resources (WA); - aviation and aerial firefighting; - fishing, farming and retail fuel customers in South-East South Australia; - New Zealand forestry, export and industrial customers. **Independent characterisation.** K&S is best understood as a commodity-oriented industrial logistics carrier with a property-backed balance sheet and a dominant family shareholder. Its earnings are driven by three things: - construction and steel volumes; - its ability to pass through input costs (labour, fleet, insurance, property) under typically annual price reviews; - operating discipline, after a long programme of exiting low-return contracts. It is not a parcel or express business; it exited express in 2000. The fuel segment acts as a counter-cyclical, high-margin cash generator. The NZ business is a stable but sub-scale adjunct.

Revenue$0.5B
Employees1,522
Market CapN/A
Founded1945
Mount Gambier, Australia
K+S

K+S AG

Premium
Information Technology

K+S is Europe's leading — and one of the world's six or seven largest — producers of potash and magnesium fertilizers, combined with one of Europe's largest salt businesses. After divesting its North and South American salt operations (Morton Salt, Windsor Salt, K+S Chile) to Stone Canyon in 2021, the group has become a focused minerals company with two customer segments: Agriculture (~70% of revenue: potassium chloride and high-margin specialty fertilizers such as Korn-Kali, Patentkali, KALISOP and EPSO products) and Industry+ (~30%: industrial and pharmaceutical potash and magnesium compounds, de-icing, food, water-softening and chemical salts, plus waste-management services). Its production base comprises six German underground potash/magnesium operations centered on the Werra complex and Zielitz, the greenfield Bethune solution mine in Saskatchewan, Canada, and European salt plants. Its competitive identity rests on a unique specialties portfolio and proximity to European customers; its structural challenge is a high-cost, environmentally constrained German asset base whose transformation ("Werra 2060") and the Bethune ramp-up absorb most cash flow through 2028. --- **What K+S does.** K+S mines potash- and magnesium-bearing crude salts and rock salt, and processes them into fertilizers, industrial chemicals, and salt products. The company's own boilerplate (FY2025 press materials) describes its mission as enabling farmers to secure the world's food supply, keeping industries running, enriching consumers' daily lives and ensuring winter road safety, with production on two continents and a global distribution network. Management explicitly frames the group as "realigning" toward fertilizers and specialties, becoming leaner, more cost-efficient, more digital and more performance-oriented. **Business model.** K+S is a vertically integrated, asset-heavy commodity-plus-specialty producer. Value is created at the mine and processing plant; it owns (or holds long-dated concessions over) its deposits and controls logistics assets (port terminals, rail/barge contracts). Revenue is almost entirely product sales (>95%); services (REKS waste management/underground reuse, logistics) are a small, non-separately-disclosed share. There is no subscription or licensing revenue of significance. **Revenue model mix (FY2025, company data):** Source: K+S Q4/2025 Facts & Figures. Note: KCl + specialties sum (2,547.7) equals the Agriculture segment total including trade goods. **Value-chain position.** Upstream (mining, beneficiation, granulation) through to distribution: K+S sells to fertilizer distributors, cooperatives, blenders and importers (overseas: Brazil, Southeast Asia, North America), to chemical/pharma/food industries, to municipalities/road authorities (de-icing tenders) and, via retailers, to consumers (water softening, table salt in some markets). It does not produce nitrogen or phosphate. **Customer types and end-markets:** (i) Agriculture — row crops (Brazil soy/corn/sugarcane), specialty and chloride-sensitive crops in Europe (potatoes, fruit, vegetables, vines), oil palm and rice in Asia; (ii) Industry — chemicals (KOH production, PVC/chlor-alkali salt), oil & gas drilling brines, food processing, pharmaceuticals and dialysis (high-purity salts), animal feed, water treatment; (iii) Communities — municipal and highway de-icing; (iv) Consumers — water-softener salt, table salt. **Independent characterization.** K+S is best understood as a high-cost, specialty-tilted potash producer with a counter-cyclical (weather-driven) salt hedge. Unlike Nutrien or Mosaic, its legacy German operations are conventional underground mines with comparatively deep, low-grade, mixed deposits (kieserite-, carnallite- and sylvinite-bearing) that require energy-intensive hot-leach or flotation processing and generate large volumes of saline residues — the root of its water-disposal and tailings-pile constraints. That geology, however, is also its moat: the magnesium and sulfate content enables a specialties portfolio (sulfate of potash, kieserite, Epsom salt, K-Mg compound fertilizers) that commands a premium (FY2025 specialties average €374.6/t vs. KCl €309.6/t). Bethune in Canada provides a lower-cost, USD-denominated, solution-mined KCl platform but has struggled to reach nameplate capacity. Earnings are levered to the Brazilian KCl price, the USD/EUR rate, European natural gas, and winter severity.

Revenue$4.1B
Employees11,330
Market CapN/A
Founded1889
Kassel, Germany
JXTG(ENEOS)

JXTG Holdings (ENEOS)

Premium
Information Technology

| Item | Detail | |---|---| | Legal name | ENEOS Holdings, Inc. | | Former names | JX Holdings, Inc. (April 2010 – March 2017); JXTG Holdings, Inc. (April 2017 – June 2020) | | Founding year | Holding company established 1 April 2010; Group lineage traces to Nippon Oil Company, founded 1888 | | Incorporation jurisdiction | Japan (Kabushiki Kaisha); Corporate Number 9010001131743 | | Headquarters | 1-2, Otemachi 1-chome, Chiyoda-ku, Tokyo, Japan (per AGM notice, 25 June 2026) | | Stock exchanges / tickers | Tokyo Stock Exchange Prime Market (5020); Nagoya Stock Exchange Premier Market (5020); US OTC ADR JXHLY and ordinary JXHGF | | ISIN | JP3386450005 | | CUSIP | Not applicable for the ordinary share (Japanese issuer) | | Fiscal year end | 31 March | | Accounting standard | IFRS | | Employees (consolidated) | 34,099 as of 31 March 2026 (ENEOS Quick Facts) | | Auditor | Ernst & Young ShinNihon LLC (per Yuho; not re-verified for FY2025 in this review) | | Share price (latest) | approx. ¥1,252 (TSE close, 6–7 October 2026; Zonebourse quote) | | Market capitalisation | approx. ¥3.3–3.4 trillion (≈2,707m issued shares as of August 2026, before cancellation of shares repurchased under the May 2026 programme) | | Website | https://www.hd.eneos.co.jp | | Credit rating | JCR long-term issuer AA-, Stable; CP J-1+ (affirmed 7 September 2026) | | Representative | Miyata Tomohide, Representative Director, CEO | | Board chair | Kawasaki Hiroko (outside director) | The name supplied ("JXTG Holdings (ENEOS)") refers to a former name of the entity now legally called ENEOS Holdings, Inc. (Japanese: ENEOSホールディングス株式会社). JXTG Holdings changed its name to ENEOS Holdings on 25 June 2020. The entity profiled is the active, publicly listed parent of the ENEOS Group. The company type supplied ("Public company") is correct. | Metric | FY2023 | FY2024 | FY2025 | |---|---|---|---| | Consolidated employees (period-end, persons) | 44617 | 34238 | 34099 | Sources: FY2023 figure per Yahoo Finance profile (period-end March 2024, includes JX Advanced Metals, then a consolidated subsidiary); FY2024 per EDINET-derived atsoho profile; FY2025 per ENEOS Quick Facts (31 March 2026). The step-down between FY2023 and FY2024 reflects the deconsolidation of JX Advanced Metals (JXAM) following its March 2025 IPO, not organic headcount reduction. ENEOS Holdings is Japan's largest integrated energy group and the dominant domestic refiner-marketer, holding roughly half of Japanese fuel-oil sales through more than 11,000 branded service stations and 1.64 million barrels per day of crude-processing capacity (31 March 2026). Its earnings engine is the Petroleum Products segment, which generated ¥300.2bn of the Group's ¥474.4bn FY2025 operating profit excluding inventory effects, supplemented by upstream oil and LNG (ENEOS Xplora), synthetic rubber and battery materials (ENEOS Materials), power generation and retail (ENEOS Power), renewables (ENEOS Renewable Energy), and a 35.3% equity stake in semiconductor-materials leader JX Advanced Metals. Under its Fourth Medium-Term Management Plan (FY2025–FY2027) the company is shifting from a shrinking domestic fuel franchise toward overseas downstream growth — exemplified by the US$2.17bn Chevron Asia-Pacific acquisition and the ~US$1.3bn TPC Group butadiene deal — while targeting ROE of 10%+, ROIC of 6%+ and progressive dividends. --- ### What the company does ENEOS Holdings is a pure holding company. Since a 1 April 2024 reorganisation it owns a set of operating companies directly, each aligned to a reporting segment: **ENEOS Corporation:** crude procurement, refining, petrochemicals (aromatics such as paraxylene and benzene; olefins), lubricants, LPG/gas, hydrogen, fuel marketing through the ENEOS service-station network, overseas fuel trading and marketing, SAF/biofuels and synthetic fuels development. **ENEOS Xplora:** (renamed from JX Nippon Oil & Gas Exploration in January 2025) — oil and natural-gas exploration and production, LNG participation, drilling (ENEOS Drilling / Japan Drilling), and CCS/CCUS (Petra Nova, Texas). **ENEOS Materials:** synthetic rubber (notably solution-polymerised styrene-butadiene rubber, SSBR, for fuel-efficient tyres), elastomers, battery binders, and other functional materials; built on the elastomers business acquired from JSR in 2022. **ENEOS Power:** thermal power generation (including the Goi and Kawasaki natural-gas plants via affiliates, and Muroran biomass), wholesale and retail electricity and city gas. **ENEOS Renewable Energy:** (formerly Japan Renewable Energy) — solar, onshore wind, offshore wind development, battery storage. **Other:** NIPPO (road paving and civil engineering), real estate, shipping (residual), finance, research, and the equity-method interest in JX Advanced Metals. ### Business and revenue model ENEOS's revenue is overwhelmingly product-based: the Petroleum Products segment accounted for approximately 88% of Group revenue in FY2025 (¥10,395.3bn including inter-segment sales, of consolidated ¥11,765.5bn). Revenue is commodity-linked and largely a pass-through of crude costs; profitability depends on refining and marketing margins, refinery utilisation, petrochemical spreads, and — critically for reported earnings — inventory valuation effects (ENEOS uses the weighted-average method, so rising crude prices create inventory gains and falling prices create losses). Management therefore steers on "operating profit excluding inventory valuation". Service, subscription and licensing revenues are small. Examples of non-product revenue include construction contracting (NIPPO), electricity supply contracts (a quasi-recurring retail model), and the Matlantis AI materials-simulation SaaS (co-developed with Preferred Networks), but none is separately disclosed at a material scale. A precise product/service/subscription/licensing revenue split is not publicly disclosed. ### Value-chain position ENEOS spans the entire hydrocarbon chain in Japan: upstream equity production (Malaysia, Indonesia, Vietnam, UAE via Abu Dhabi Oil, US), crude shipping (residual crude tankers after the 2025 transfer of other marine operations to NYK), import terminals (Kiire base), refining and petrochemicals (11 domestic refining/manufacturing sites), logistics, wholesale, branded retail, and downstream materials (synthetic rubber). It is also positioned in power generation and retail. ### Customer types and end markets | Customer type | Representative end market | Primary segment | |---|---|---| | Retail motorists (via dealers and company-operated stations) | Road transport fuels | Petroleum Products | | Commercial fleets, trucking (e.g., ENEOS Wing truck stops) | Logistics | Petroleum Products | | Airlines | Jet fuel, SAF | Petroleum Products | | Shipping lines | Bunker fuel, green methanol (in development) | Petroleum Products | | Industrial users, utilities | Fuel oil, LNG, power | Petroleum Products, Electricity | | Chemical producers | Paraxylene, benzene, olefins, butadiene | Petroleum Products | | Tyre makers | SSBR and elastomers | High Performance Materials | | Battery makers | Binders for lithium-ion batteries | High Performance Materials | | Households and SMEs | Retail electricity and city gas | Electricity | | Corporate offtakers | Renewable PPAs | Renewable Energy | | Public-sector road authorities | Road paving | Other (NIPPO) | | Export markets (Asia-Pacific, Australia) | Refined products | Petroleum Products | ### Company's own description (paraphrased from the Fourth MTP and Integrated Report) The company describes its mission as harnessing natural resources for the common good through energy, resources and materials, and frames its strategy around "supporting today's normal, taking the lead for tomorrow's normal" — i.e., securing stable supply of conventional energy while building low-carbon (LNG, biofuels, SAF) and decarbonisation (renewables, CCS, hydrogen, synthetic fuels) businesses. It highlights its approximately 50% share of domestic fuel-oil sales, about 12,000 service stations (MTP figure; later updated to over 11,000), operations at 23 overseas locations in 16 countries (mainly Southeast Asia), one of Asia's leading basic-chemicals supply capabilities, and the second-largest solar and wind generating capacity in Japan via ENEOS Renewable Energy. ### Independent characterisation ENEOS is best understood as a cash-generative but structurally challenged domestic refining franchise that is using its balance-sheet strength (JCR AA-) and monetisation proceeds (JXAM IPO and follow-on sales) to (a) return capital, (b) buy growth in Southeast Asian and North American downstream assets, and (c) maintain optionality in low-carbon energy without committing heavily ahead of policy clarity. Reported earnings are highly volatile because of inventory effects and crude-price shocks, but underlying earnings have improved markedly since FY2024 owing to better refinery reliability (unplanned capacity loss fell from 9% in FY2022 to 5% in FY2024 per the MTP) and firm product margins. The 2026 Middle East conflict and the disruption of Strait of Hormuz flows have simultaneously raised supply risk and strengthened margins, a dynamic that produced exceptional FY2026 Q1 profits.

Revenue$78.6B
Employees34,099
Market CapN/A
Founded2010
Tokyo, Japan
Jupiter

Jupiter Energy Limited

Premium
Information Technology

Jupiter Energy is a micro-cap, single-asset onshore oil producer. It holds 100% of the Block 31 licence area (Contracts 2275/4803), about 123 km², in the prolific Mangistau Basin of western Kazakhstan, roughly 80 km from the Caspian port city of Aktau. Since 2008 the company has discovered three oilfields: Akkar North (East Block), Akkar East and West Zhetybai. All three now operate under 25-year Full Commercial Production Licences running to 2045–2046. Production is about 190,000–225,000 barrels a year from four to five active wells. All oil is sold into the Kazakh domestic market on a prepaid basis through 50%-owned trading joint ventures and to local mini-refineries. Group revenue is A$10–11 million a year. The company is controlled by its major shareholder and Noteholder, Waterford Petroleum (about 60%). It has been operationally cash-flow positive since FY2023. Its investment case depends on converting its large Kazakh-certified reserve base (about 36.5 MMbbl 2P) into production through new drilling, which is currently unfunded. --- ### Company's own description The FY2025 Annual Report defines Jupiter's principal continuing activities in two lines: exploration for oil and gas in Kazakhstan, and the appraisal, development and production of oil and gas properties in Kazakhstan. The H1 FY2026 report states the Board's long-standing objective: to develop Jupiter into a full-cycle exploration and production company with a meaningful production profile and a sizeable 2P reserve base. ### Independent characterisation Jupiter is best understood as a small, low-decline, conventional onshore crude producer with an outsized reserve base relative to its production. Its economics are shaped by three Kazakh-specific features. 1. **Domestic market obligation and pricing.** Kazakh regulation sets monthly quotas for oil that must be sold domestically. Domestic crude prices sit well below Brent. In the June 2026 quarter Jupiter realised about US$56/bbl on quota sales to a major refinery and about US$40/bbl on mini-refinery sales, for a blended ~US$52/bbl including VAT. Export sales are permitted for volumes above the quota. However, export netbacks after taxes, logistics and trader discounts have been unattractive since 2022. Routing constraints linked to the Russia–Ukraine conflict are the main reason. As a result, Jupiter has sold essentially 100% domestically since April 2023. 2. **Mandatory trading-JV structure.** Legislation effective January 2023 requires producers selling to major domestic refineries to do so through a joint-venture trading vehicle. Jupiter holds 50% of each JV, operated on an "open book" basis. It recognises its share of JV profits through equity accounting: A$86,285 in FY2025 and A$284,726 in H1 FY2026. 3. **Gas utilisation compliance.** Kazakhstan's Subsoil Code prohibits flaring of associated gas once fields are in commercial production. Jupiter's output was constrained for years until it installed 100% gas-utilisation infrastructure. That work was completed in March 2023 (interim solution). Integration into MangistauMunaiGas (MMG) gas infrastructure followed for the Akkar fields (November 2024) and West Zhetybai (December 2025). ### Business and revenue model | Dimension | Characterisation | |---|---| | Revenue model | 100% product sales (crude oil). No service, subscription or licensing revenue. | | Revenue recognition | Point in time. At the wellhead for mini-refinery sales; when oil enters the KTO pipeline for major-refinery domestic sales (FY2025 AR Note 1). | | Commercial terms | Prepaid sales. Traders and JVs advance cash before delivery. Contract liabilities were A$1.46m at 31 Dec 2025, representing about 2,700 tonnes undelivered. | | Value-chain position | Pure upstream. Exploration, appraisal, development and production. No midstream or refining ownership, other than 50% trading-JV stakes. | | Customer types | (a) Major Kazakh state-linked refineries via 50% JV traders, under Ministry of Energy monthly quotas. (b) Local mini-refineries, at lower prices, for volumes above quota. (c) Export buyers when netbacks justify it (none since April 2023). | | End-markets | Kazakh domestic refined-products market (fuels). Indirectly, Caspian and European crude markets via the export option. | | Funding model | Operations funded entirely from prepaid oil sales (FY2023–FY2025 ARs). Growth capex depends on new equity, Noteholder or Waterford support, deferred-payment drilling contracts, or larger trader prepayments. |

Revenue$0.0B
Employees51
Market CapN/A
Founded1998
Melbourne, Australia
Junwea

Junwea Group (China) Co Ltd

Premium
Information Technology

| Field | Detail | |---|---| | Current legal name (English) | Junwea Group (China) Company Limited | | Current legal name (Chinese) | 巨美集團(中國)股份有限公司 | | Stock short name | JUNWEA GROUP (effective 3 June 2026, per HKEX trading arrangement notice dated 1 June 2026) | | Former names | Hands Form Holdings Limited (恆新豐控股有限公司) – IPO to December 2024; China Wacan Group Company Limited (中國網成集團有限公司, later 中國網成集團股份有限公司) – December 2024 to May 2026 | | Name change dates | To China Wacan: stock short name changed 13 December 2024 (HKEX notice 10 Dec 2024). To Junwea: special resolution passed at EGM 29 April 2026; Cayman Registrar certificate issued 6 May 2026; short name effective 3 June 2026 | | Founding year (operating group) | 1989 per Simply Wall St (aggregator). Earliest filing-verified operating history: Adam Cheung joined Pak Fai Engineering in April 1990 (Annual Report 2023 biographies) | | Listed holding company incorporated | 30 January 2019, Cayman Islands, exempted company (H1 2026 interim results, note 1) | | Registered office | Windward 3, Regatta Office Park, P.O. Box 1350, Grand Cayman KY1-1108, Cayman Islands | | Headquarters / principal place of business | Unit 2B, 35/F, East Tower, Cheung Kong Center II, No. 10 Harcourt Road, Central, Hong Kong (Annual Report 2025; H1 2026 interim). *Discrepancy:* Futu lists "Two International Finance Centre" — the filing address is preferred | | Prior HQ | Room 9, 2/F, Hang Bong Commercial Centre, 28 Shanghai Street, Jordan, Kowloon (Annual Report 2023) | | Exchange / ticker | Main Board, Stock Exchange of Hong Kong; stock code 1920 (1920.HK) | | Listing date | 16 August 2019 | | ISIN | KYG4288C1015 (from client list; not re-verified post-renaming — ISINs normally persist through name changes) | | CUSIP | Not applicable / not publicly disclosed | | Fiscal year end | 31 December | | Employees | 260 at 31 Dec 2025; ~296 at 30 Jun 2026 (see trend table) | | Auditor (current) | HLB Hodgson Impey Cheng Limited (appointed 11 December 2025; re-appointed at AGM 29 June 2026) | | Principal banker | The Bank of East Asia, Limited | | Company secretary | Mr. Tsui Chun Hung (appointed 30 January 2019) | | HK share registrar | Boardroom Share Registrars (HK) Limited | | Controlling shareholder | Mr. Zhou Zhenlin via China Alliance Venture (Technology) Limited — 315,155,000 shares, ~53.63% (MarketScreener, as of 22 April 2026; before the June 2026 placing the stake was higher) | | Issued shares | 587,600,000 ordinary shares of HK$0.10 each at 30 June 2026 | | Market capitalisation | ~HK$229.2 M at HK$0.390 per share (Futu quote, 8 September 2026). Not re-verified for 11 October 2026 | | Website | www.wacan.com.hk (per Annual Report 2025). Legacy: www.handsform.com. | The entity on the identification list (Hands Form Holdings Limited, 1920.HK, ISIN KYG4288C1015, website handsform.com) still exists as the same Cayman Islands legal entity and same HKEX stock code, but has been renamed twice. | Metric | FY2022 | FY2023 | FY2024 | FY2025 | H1 2026 | |---|---|---|---|---|---| | Employees at period end (headcount, incl. directors) | 16 | 14 | 13 | 260 | 296 | | Total staff costs (HK$ M) | 5.3 | 5.6 | 5.0 | 15.3 | 24.0 | *Sources:* Annual Report 2023 (FY2022–FY2023); Annual Report 2025 (FY2024–FY2025); H1 2026 interim results (staff costs are for the six months only). The roughly twentyfold headcount increase reflects staffing of the Mainland China beauty-and-health stores. Junwea Group is a Hong Kong-listed micro-cap in transition. For three decades it was a family-controlled wet-trades subcontractor (plastering, tiling, bricklaying, marble works). It operated through Pak Fai Engineering and Ma Yau Engineering, and its customers were Hong Kong main contractors on public and private building projects. After five consecutive years of losses and a revenue collapse from HK$558 M (FY2019) to HK$87 M (FY2023), control passed in early 2025 to Shenzhen-based beauty-industry entrepreneur Zhou Zhenlin. Mr. Zhou then installed a new board and rebranded the company. He launched a franchise-like beauty and health services business in Mainland China, run through 51%-owned joint-venture store subsidiaries with local partners. The Hong Kong construction business still generates about two-thirds of revenue and anchors the company's operating history. However, the strategic narrative, the capital raised and the cost base are now oriented toward Mainland consumer services. The company is loss-making, equity-funded and highly dependent on its controlling shareholder. --- ### Company's own description (Annual Report 2025 and H1 2026 interim) The company states that it is an investment holding company whose subsidiaries are principally engaged in three businesses: (i) beauty and health services; (ii) construction services, comprising wet trades works (plastering of floors, walls and ceilings; tiling of internal and external walls and floors; bricklaying; marble works) and related ancillary works; and (iii) construction information technology services. The H1 2026 interim results list the beauty and health segment first, which signals management's reprioritisation. The FY2025 report described the beauty business as delivering facial treatments, blemish removal, skin whitening and anti-wrinkle services through physical stores in first- and second-tier Mainland cities. ### Independent characterisation In economic substance the group currently runs two unrelated businesses under one listed shell: 1. **A sub-scale, project-driven Hong Kong finishing-trades subcontractor (Ma Yau Engineering).** It wins fixed-price tenders of 1–17 months' duration from main contractors (H1 2026 interim, note 3A). It recognises revenue over time using an input (cost-to-cost) method. Its margin profile is exposed to tender pricing, variation-order recovery and the timing of works certification. Gross margins were negative from FY2021 to FY2024 and only turned positive in FY2025 because of project final-account settlements. 2. **A start-up Mainland beauty-salon network.** It operates through majority-owned (typically 51%/49%) local subsidiaries co-owned with regional partners. The model combines services with product sales (product revenue is recognised on delivery) and appears to rely on prepaid customer balances. Contract liabilities rose to HK$39.5 M at 30 June 2026, and the company itself flags prepaid-card regulation as a risk. The segment lost HK$10.3 M on HK$25.6 M of revenue in H1 2026. A third activity, a subscription construction-IT platform, is immaterial. It generated HK$366,000 in each of FY2023 and FY2024 and nil in H1 2025 and H1 2026. ### Revenue model mix | Revenue model | Segment | Approx. share of revenue (H1 2026) | Notes | |---|---|---|---| | Project/contract revenue (fixed-price, recognised over time) | Construction services | 68% (HK$54.3 M of HK$79.9 M) | Input method; retention typically held for a 12-month defects liability period | | Consumer services and product sales | Beauty and health | 32% (HK$25.6 M) | Product sales recognised on delivery; service revenue presumably on consumption of prepaid balances (policy detail not fully disclosed) | | Subscription (fixed monthly billing) | Construction IT | 0% | Practical expedient: revenue recognised as invoiced | | Licensing | — | 0% | None disclosed | ### Value-chain position, customers and end-markets | Dimension | Construction services | Beauty and health | |---|---|---| | Value-chain position | Tier-2 specialist trade subcontractor below main contractors | Store operator (via 51%-owned JVs); also sells products | | Direct customers | Hong Kong main contractors and other subcontractors | Retail consumers (predominantly female, urban) | | Ultimate project owners | Predominantly government entities and property developers (Futu company profile, derived from prospectus) | n/a | | Public vs private mix | H1 2026: public HK$20.3 M, private HK$34.1 M; H1 2025: public HK$57.7 M, private HK$7.3 M | Private (consumer) | | Concentration | FY2025: largest customer 40.7% of group revenue; top five 91.5% | Not disclosed | | Geography | Hong Kong | Mainland China — Shenzhen, Beijing, Shanghai, Wuhan, Fuzhou, Chongqing, Shenyang, Xi'an and others | | Regulatory registration | CIC Registered Specialist Trade Contractors Scheme (finishing wet trades; marble, granite and stone work) | PRC beauty-services and prepaid-card regulations (company-flagged) |

Revenue$0.0B
Employees296
Market CapN/A
Founded1989
P.O. Box, Cayman Islands
Jungbunzlauer

Jungbunzlauer Suisse AG

Premium
Information Technology

| Field | Detail | Source / note | |---|---|---| | Entity profiled | Jungbunzlauer Suisse AG, Swiss operating company of the Jungbunzlauer Group | Seaway Review, Oct 2024 | | Ultimate parent | Jungbunzlauer Holding AG, Basel | Austria-Forum; AEIOU | | Ownership | Private; Kahane family (current reference); historically via Montana Industrie-Holding AG | Austria-Forum; AEIOU | | Former / historic names | Lederer distillery business (Böhmisch Leipa); "Jungbunzlauer Spiritus- und Chemische Fabrik" lineage; Jungbunzlauer Ges.m.b.H. (Austria) | AEIOU; Austria-Forum. Exact historic legal names not fully verified | | Founding year | 1867 (molasses distillery in Jung-Bunzlau / Mladá Boleslav, Bohemia, founded by Ignatz Lederer). Some sources trace roots to an 1859 Lederer distillery in Böhmisch Leipa | Austria-Forum; AEIOU | | Incorporation jurisdiction | Switzerland (Canton Basel-Stadt) | Seaway Review | | Headquarters | Basel, Switzerland. Street address per company website: St. Alban-Vorstadt 90, 4002 Basel | Address from company website; not re-verified in this research cycle | | Stock exchange / ticker | None (not listed) | — | | ISIN / CUSIP | Not applicable (no listed equity); no public debt ISIN identified | — | | Fiscal year end | 31 December (inferred: Austrian group affiliate files accounts with 31.12 balance date) | Austrian company register (evi.gv.at) | | Employees (latest) | About 1,400 ("nearly 1,400 colleagues") | Company boilerplate, PR Newswire, 3 Aug 2026 | | Employee 3-year trend | Not publicly disclosed as a consolidated series; site data points: Pernhofen ~450; Ladenburg ~330; Port Colborne 165 (2024) with up to 50 additions planned | Austria-Forum; ausbildung.de; Invest Ontario, 2024 | | Revenue scale | About CHF 1.3 billion (company self-description) | PR Newswire, 6 Nov 2025 and 3 Aug 2026 | | Auditor | Not publicly disclosed | — | | Market capitalisation | Not applicable (private) | — | | Website | www.jungbunzlauer.com | — | | Customers served | More than 130 countries | FoodBev, 4 Aug 2026 | | CEO | Bruno Tremblay (since 1 May 2024; year inferred from timeline) | Personal Care Magazine | | Corporate claim | "From nature to ingredients®" | Company materials | Jungbunzlauer is one of the world's leading and longest-established producers of biodegradable, fermentation-derived specialty ingredients. Its business is anchored in citric acid, where it is one of very few remaining large-scale producers outside China, alongside citrates, gluconates, lactics, xanthan gum, the polyol sweetener erythritol, mineral salts and salt-replacement systems. Founded in Bohemia in 1867 and headquartered in Basel since the 20th century, the family-owned group converts renewable carbohydrates (mainly corn) into ingredients for food and beverage, nutrition and health, pharmaceuticals, personal care, home care/detergents and technical applications. Production is concentrated at four large integrated fermentation sites: Austria, Germany, France and Canada. A fifth site in Illinois, acquired in 2025, is its first in the United States. With roughly CHF 1.3 billion in revenue and about 1,400 employees, Jungbunzlauer competes on quality, traceability, Western-origin supply security and sustainability against lower-cost Chinese volume producers. Its current strategy is a capital-intensive North American capacity build-out. --- ### What the company does Jungbunzlauer manufactures ingredients by microbial fermentation of renewable carbohydrate raw materials, mainly corn, followed by downstream purification, crystallisation, neutralisation (to make salts) and blending. The company's long-standing self-description is that it uses renewable carbohydrate raw materials, mainly derived from corn, and transforms them through natural fermentation into readily biodegradable, ecologically safe ingredients (company boilerplate reproduced in Prepared Foods). The current boilerplate (Aug 2026) positions Jungbunzlauer as a leading producer of high-quality, sustainable ingredients from natural sources. It serves food and beverage, nutrition, health, home and personal care, among other industries (PR Newswire, 3 Aug 2026). The company presents its portfolio in functional families: acidulants, texturants, sweeteners and minerals (Food Business MEA, Sept 2025, describing the portfolio). ### Business model | Dimension | Characterisation | |---|---| | Revenue model | Almost entirely product sales (B2B ingredient sales by tonnage under spot, annual and multi-year supply contracts). No material service, subscription or licensing revenue identified | | Product vs. service mix | Effectively 100% product; application-technology support is provided as a value-added service bundled into product sales, not invoiced separately | | Value-chain position | Mid-stream: buys agricultural feedstock (corn, glucose, in Canada via an integrated corn wet mill) and energy, then sells functional ingredients to formulators and brand owners. Partly backward-integrated (Port Colborne corn wet milling; Pernhofen glucose production) | | Pricing dynamics | Commodity-linked for citric acid and bulk citrates, with prices heavily influenced by Chinese export pricing. Specialty pricing for salt replacers, mineral salts, specialty xanthan grades and plasticisers | | Channel | Direct sales to large multinationals plus distributors in smaller markets (distributor network not publicly itemised) | | Customer types | Multinational food and beverage manufacturers, meat and poultry processors, bakery and dairy producers, dietary-supplement and pharma companies, personal-care and cosmetics formulators, detergent and cleaning-product makers, polymer/plastics compounders, construction-chemical and industrial users | | End markets | Food and beverages; nutrition and health (supplements, fortification); pharmaceuticals; personal care and cosmetics; home care (detergents, cleaners); technical/industrial (plasticisers, concrete admixtures, metal treatment) | ### Company's own description vs. independent characterisation **Company's own description.** Jungbunzlauer does not publish an annual report. Its press-release boilerplate (Nov 2025 and Aug 2026) describes: - a leading producer of high-quality, sustainable ingredients from natural sources; - founded more than 150 years ago; - grown into a CHF 1.3 billion company with nearly 1,400 colleagues "committed to a healthier, more sustainable future"; - operating large-scale fermentation facilities across Europe and North America and serving more than 130 countries. **Independent characterisation.** Jungbunzlauer is best understood as a Western, fermentation-based specialty-commodity hybrid. Its economic engine is citric acid and citrates. This is a globally traded, China-dominated category. Jungbunzlauer and Belgium's Citrique Belge have together represented 100% of EU citric-acid production in successive EU trade-defence proceedings (Commission Implementing Regulations (EU) 2015/82 and 2021/607). This makes Jungbunzlauer a structurally important beneficiary of EU anti-dumping duties on Chinese citric acid, which have been in force since December 2008. Around this core, the group has layered higher-value derivative and adjacent fermentation products: - gluconates and glucono-delta-lactone (GdL); - lactics; - xanthan gum; - erythritol; - mineral salts for fortification; - the sub4salt® salt-replacement family; - citrate-ester plasticisers. These products share feedstock, fermentation know-how and site infrastructure with the core. The firm's differentiation rests on: - non-Chinese, regionally produced supply (increasingly valuable to North American buyers given tariff and supply-chain risk); - quality and regulatory dossiers; - sustainability credentials (renewable feedstock, biodegradability, carbon-neutral site design claims); - application know-how.

RevenueN/A
Employees1,400
Market CapN/A
Founded1867
Basel, Switzerland
Jumbo

Jumbo Interactive Limited

Premium
Information Technology

Jumbo Interactive is a Brisbane-headquartered, technology-led digital lottery and prize-draw group that has moved from a single-market Australian lottery ticket reseller to a diversified international business. Its core B2C asset, Oz Lotteries, resells The Lottery Corporation's national jackpot games (Powerball, Oz Lotto, Saturday Lotto) online under long-term reseller agreements, alongside charity and proprietary games. Its proprietary Jumbo Lottery Platform (JLP) is licensed as SaaS to government and charity lotteries, including Lotterywest and, since FY26, RSL Queensland. Managed Services subsidiaries in the UK (Gatherwell, StarVale) and Canada (Stride) run end-to-end charity lotteries. The October 2025 acquisitions of Dream Car Giveaways (UK) and Dream Giveaway (US) created a fourth segment and an international B2C growth engine. FY26 underlying EBITDA reached a record A$85.2m on revenue of A$193.6m. The equity, however, trades near multi-year lows because of jackpot-cycle weakness in its Australian core, a debt-funded change in strategy and a halved dividend. --- ### Company's own description (latest disclosures) In its FY26 release, Jumbo describes itself as a business that combines technology, creativity and purpose to deliver digital lottery and prize-draw experiences. B2B SaaS platforms and Managed Services power government and charity fundraising programs, while its B2C brands (Oz Lotteries, Dream Car Giveaways and Dream Giveaway) connect millions of customers to prizes and good causes. It operates across Australia, the United Kingdom and North America. Management's FY26 strategic framing is that Jumbo is now "a diversified, international, technology-enabled lottery and prize draw company". The stated vision is to be at the heart of the world's best winning experiences, and the mission is to create premium digital entertainment experiences that people love. [FY26 Media Release; FY26 Presentation slides 24 and 26] ### Independent characterisation Economically, Jumbo is four businesses on one proprietary software and digital-marketing stack: 1. **Australian B2C lottery reseller (Lottery Retailing).** This is a high-margin, capital-light distribution franchise. Jumbo earns a commission-like revenue margin (24.7% of TTV in FY26) on tickets sold through Oz Lotteries. It pays The Lottery Corporation (TLC) a service fee that rose from 1.5% of subscription price in FY21 to 4.65% from FY24 onward. Volumes depend heavily on the frequency and size of Division 1 jackpots, which makes this a cyclical, exogenously driven earnings stream. [FY26 Presentation slide 36, note 1] 2. **B2B SaaS.** JLP is licensed to external lotteries (Lotterywest's "Oz.Lotterywest" channel, charity lotteries and RSL Queensland) on a percentage-of-TTV model (external revenue margin of about 4.1% in FY26). JLP also provides the platform for Jumbo's own Lottery Retailing through an intersegment fee (A$30.7m in FY26). Segment EBITDA margins of 62–68% make this the highest-quality earnings stream. [FY26 Presentation slide 17] 3. **Managed Services (UK and Canada).** This segment runs outsourced charity lottery operations: platform, compliance, marketing, customer service and prize fulfilment for hospices, hospitals and charities, at about a 9.6% revenue margin on TTV and a 29.6% EBITDA margin. [FY26 Presentation slide 18] 4. **Dream Giveaways (UK and US B2C prize draws).** Jumbo owns the product here, setting prizes (mainly cars, cash and property), draw cadence and pricing. Revenue margin is far higher (35% UK, 80% US, underlying), with heavy marketing (14–25% of TTV) and 40–42% EBITDA margins. [FY26 Presentation slides 19 and 40] ### Revenue model mix (FY26, reported revenue A$193.6m) | Revenue type | Segment(s) | FY26 revenue (A$m) | % of group | Nature | |---|---|---|---|---| | Reseller commission / ticket margin (B2C) | Lottery Retailing | 103.5 | 53.5% | Transactional, jackpot-sensitive | | SaaS platform licensing (external, % of TTV) | SaaS | 11.8 | 6.1% | Recurring, contracted | | Managed-service fees (% of TTV) | Managed Services | 28.4 | 14.7% | Recurring, contracted (renewal risk) | | Prize-draw entry revenue (B2C product owner) | Dream Giveaways | 49.8 (53.6 underlying) | 25.7% | Transactional, marketing-driven | | Total | — | 193.6 | 100% | — | [FY26 Presentation slides 17–19 and 35. Percentages are derived.] ### Value-chain position Jumbo does not hold lottery licences for the Australian national games. It sits downstream of the licensed operator (TLC) as an authorised digital reseller, and upstream of charity and government lotteries as a technology and operations vendor. In UK and US prize draws it is the product owner and operator under the applicable prize-competition and sweepstakes frameworks. In its "Structural Moats" slide, management lists four sources of advantage: licences and regulatory frameworks, more than 5 million active players, embedded platform switching costs, and physical execution capability (prize sourcing and logistics). [FY26 Presentation slide 43] ### Customer types and end-markets | Customer type | Examples | Segment | |---|---|---| | Retail lottery players (Australia) | 735,851 active Oz Lotteries players over 12 months to FY26 | Lottery Retailing | | Government lottery operators | Lotterywest (Western Australia) | SaaS | | Charity lottery operators (Australia) | RSL Queensland (largest prize-home lottery in Australia, about A$200m TTV a year); other charity partners | SaaS | | UK charities and hospices | Gatherwell (weekly lotteries for good causes), StarVale clients (e.g., St Helena Hospice from May 2024) | Managed Services UK | | Canadian charities and hospital foundations | Stride Management Corp. clients | Managed Services Canada | | Prize-draw consumers (UK) | About 0.8m active customers | Dream Giveaways UK | | Prize-draw consumers (US) | About 0.2m active customers | Dream Giveaways US | [FY26 Presentation slides 8, 11 and 36]

Revenue$0.1B
Employees250
Market CapN/A
Founded1995
Toowong, Australia
Jubilant

Jubilant Pharmova Limited

Premium
Information Technology

Jubilant Pharmova is an India-domiciled, North America-centric specialty pharmaceutical and pharmaceutical-services group that has deliberately abandoned commodity chemistry in favour of high-barrier, licence-protected niches. Roughly 81% of revenue originates in the United States and 94% is denominated in US dollars — an unusual profile for an Indian mid-cap. Its economic core is radiopharmaceuticals: it is a leading North American manufacturer of SPECT diagnostic agents, operates the second-largest US radiopharmacy network (45 sites serving c.1,800 hospitals), holds a monopoly position in Iodine-131 for thyroid indications, and is the innovation leader in Rubidium-82 cardiac PET through Ruby-Fill. Adjacent to this sit the second-largest US allergenic-extract franchise (sole domestic venom supplier), a fast-scaling sterile-injectables CDMO at Spokane, Washington, an integrated Indian CRDMO, a rebuilt generics business, and an early-clinical oncology pipeline. The investment question is execution: capability is not in doubt; conversion of heavy capital deployment into returns, and durable FDA compliance, are. | Metric | FY2024 | FY2025 | FY2026 | |---|---|---|---| | Global employees (approximate) | 5100 | 5400 | 5500 | *Note: the company discloses headcount only as an approximate global figure ("approx. 5,500") in investor materials rather than as an audited year-end number. The FY2024 and FY2025 figures above are indicative reconstructions from successive investor presentations and third-party data aggregators (TipRanks records 5,399). Precise audited year-end headcount is not publicly disclosed in a consistent series.* --- ### The company's own characterisation Jubilant Pharmova describes itself in its FY2026 disclosures as "a company with global presence that is involved in Radiopharma, Allergy Immunotherapy, CDMO Sterile Injectables, Contract Research Development and Manufacturing Organisation (CRDMO), Generics and Proprietary Novel Drugs businesses." Its investor materials position the group as "a diversified pharmaceutical company" with a stated strategic emphasis on "specialty products and services and Dollar revenues," operating six manufacturing facilities, three research facilities, and 45 radiopharmacies, serving over 50 countries including all major regulated markets, with a workforce of approximately 5,500. The group's stated corporate values — "Caring, Sharing, Growing" — are inherited from the wider Jubilant Bhartia Group. ### Independent characterisation The self-description understates the degree to which this is really two businesses with radically different economics stapled to a venture-stage third. **Business one — the specialty franchise (Radiopharmaceuticals, Allergy Immunotherapy).** These are the profit engines. Radiopharmaceutical manufacturing carried a 44% EBITDA margin in FY2026 (47% in FY2025, 50% in FY2024); Allergy Immunotherapy carried 35%. Both are protected by structural moats that have little to do with patents: radioactive isotopes decay on a timescale of hours to days, so the business is really a *just-in-time logistics business wrapped around a nuclear licence*. Every treatment site requires a Nuclear Regulatory Commission licence plus state, local and hospital-level approvals; authorised nuclear pharmacists require at least 4,000 hours of specialist training. Allergenic extracts sit behind an even odder moat: most of the portfolio operates under grandfathered approvals, any genuinely new product requires a Biologics License Application, and the US subcutaneous immunotherapy market has consolidated to three players. Jubilant is the *sole* US supplier of venom immunotherapy extracts. **Business two — the services franchise (CDMO Sterile Injectables, CRDMO).** These are capital-hungry, margin-thinner, but currently growing fastest. Sterile fill-and-finish is a capacity business: contracts typically run three years or more with auto-renewal, technology transfer takes 18–24 months, switching costs are consequently very high, and 90%+ of business is repeat. Jubilant counts 5 of the top 20 global pharmaceutical companies as customers and reports a 92% customer retention rate. The Indian CRDMO arm (Jubilant Biosys) sells scientist-hours and process chemistry, with 8 of the top 20 pharma companies as clients and 85+ integrated discovery programmes delivered. **Business three — Proprietary Novel Drugs (Jubilant Therapeutics).** Pre-revenue, cash-consuming (roughly ₹16 crore of EBITDA loss in FY2026), and optionality-driven. **Revenue model.** Overwhelmingly product sales and manufacturing services, not licensing or subscription. Approximately 54% of FY2026 revenue was product sales (radiopharmaceuticals, radiopharmacy compounded doses, allergenic extracts, generic formulations, APIs) and approximately 36% was contract manufacturing and research services. There is essentially no royalty, milestone or subscription revenue today; the Proprietary Novel Drugs unit has explicitly stated it will "explore monetization through licensing or external fund raising," which would introduce a licensing revenue line for the first time. **Value chain position.** Unusually, Jubilant occupies *both* the manufacturing and distribution rungs in radiopharma. It manufactures the radiopharmaceutical (Kirkland/Montreal, Canada) *and* compounds and distributes patient-ready doses through its own radiopharmacy network and fleet. This forward integration is the single most important structural feature of the company: it converts a product-manufacturing margin into a manufacturing-plus-distribution margin and gives the company channel control over hospital customers. **Customer types and end-markets.** Hospitals, imaging centres and cardiology practices (radiopharma; c.1,800 hospitals served); allergists and ENT specialists (c.2,000 US practitioners); innovator pharmaceutical and biotechnology companies (CDMO and CRDMO); generic distributors, wholesalers and B2B2C partners in 50+ markets (generics). End-markets served: oncology diagnostics and therapy, cardiology, nephrology, pulmonology, endocrinology, allergy and immunology, cardiovascular, CNS, gastrointestinal and multi-specialty generics.

Revenue$1.0B
Employees5,500
Market Cap$1.6B
Founded1978
Uttar Pradesh, India
Ju

Ju Teng International Holdings Limited

Premium
Information Technology

Ju Teng is a Taiwanese-managed, Hong Kong-listed contract manufacturer of notebook-computer and 2-in-1 casings. Through the late 2000s and 2010s it described itself as holding more than 30% of the global notebook-casing market. It is a component supplier to the Taiwanese ODM ecosystem, including Compal, Wistron and other large ODMs and brands. It has full process breadth across mould-making, plastic injection, magnesium-aluminium die-casting, metal stamping, CNC machining, composites, anodizing and surface finishing. The business peaked with pandemic-era revenue of HK$11.3 billion in FY2021. It has since shrunk by roughly half as notebook demand normalised, tariffs pushed ODM assembly out of China, and Ju Teng's China-heavy footprint became stranded. The company has reported losses for three consecutive years (FY2023–FY2025), and the H1 2026 loss of HK$813 million was severe. It is now mid-way through a capacity migration to Vietnam and is the subject of a conditional change-of-control. Lens Technology has agreed to buy the founding Cheng family's 27.81% and plans a general offer at HK$2.20 per share. --- **Company's own description.** The FY2025 annual report and FY2026 interim report describe Ju Teng in consistent terms: - It is an investment holding company whose subsidiaries manufacture and sell casings for notebook computers and handheld devices. - Notebook computer casings and 2-in-1 computer casings remain its core products and main revenue source. - It positions itself as one of the world's leading notebook casing manufacturers, with long-standing relationships across its upstream and downstream supply chain. The FY2025 chairman's statement sets out four priorities: - strengthening the group's ability to win orders in higher-value areas such as high-end metal casings; - following the "high-end casing and AI PC" trend; - consolidating domestic (PRC) factories; - accelerating capacity ramp-up in Vietnam. **Business model.** Ju Teng is a build-to-order, project-based component manufacturer: **Revenue recognition:** 100% of revenue is "sale of casings for notebook computer and handheld devices", recognised at a point in time on delivery. Payment terms are generally 60–120 days (FY2025 results, note 3). **Contracts:** Customers buy by individual purchase order. The group has no long-term sales contracts with any major customer (AR2025, "Relationships with key stakeholders"). **Revenue mix:** Effectively 100% product revenue. There is no subscription, licensing or service revenue of any significance. Rental, subsidy and compensation income are booked below gross profit in "other income". **Value chain position:** Tier-1 mechanical-component supplier. Ju Teng sells casings (lid/A-cover, bezel/B-cover, palm-rest/C-cover and bottom/D-cover sets, plus 2-in-1 enclosures) to ODMs and brand owners, who integrate them into finished notebooks. Delivery-location data show this geographically: most revenue is "delivered to" mainland China, where ODM final assembly historically sat. Vietnam emerged as a delivery destination in 2025–2026. **Embedded ODM partnerships:** Ju Teng co-owns subsidiaries with its two most important ODM customers: - Wistron is a substantial shareholder of Mindforce Holdings Limited, a non-wholly-owned Ju Teng subsidiary. - Compal is a substantial shareholder of Wah Yuen Technology Holding Limited, another non-wholly-owned subsidiary. - Sales to both are disclosed continuing connected transactions under three-year master sales agreements running to 31 Dec 2026 (AR2025, Report of the Directors). **Customer types and concentration (FY2025, AR2025):** - Five largest customers: about 81% of revenue. - Largest customer: about 22%. - Five largest suppliers: below 30% of purchases. - Four customer groups each exceeded 10% of revenue in FY2025: HK$1,268.8m, HK$1,223.6m, HK$1,100.4m and HK$660.8m. - The third and fourth match the disclosed connected-transaction sales to the Compal Group (HK$1,100.4m) and the Wistron Group (HK$660.8m). **End-markets served:** - Notebook PCs, both consumer and commercial (core). - 2-in-1/convertible PCs. - Handheld devices. - Historically, TV casings and "customised products" (third-party profile). - Small and emerging: automotive parts and electric-bicycle components. These are cited in the FY2025 biography of the senior manager running Compal Precision Module (Jiangsu) and in the Vietnam strategy, which names "notebook casings and automotive parts". **Independent characterisation.** Ju Teng is a scale manufacturer with high fixed costs in a commoditised, cyclical, customer-concentrated niche. Key features: **High operating leverage:** Depreciation alone was HK$573m in FY2025, about 10% of revenue. When utilisation falls, gross margin collapses: from 10.7% in FY2021 to 2.9% in FY2024. In H1 2026, HK$510m of idle-capacity cost was moved out of cost of sales into "other expenses". **Structural FX mismatch:** Revenue is mainly in US$, costs mainly in RMB, and borrowings mainly in US$. Renminbi appreciation directly hurts reported earnings: FX losses were HK$105m in FY2025 and HK$211m in H1 2026. **Strategic problem:** This is geographic, not technological. Notebook ODMs are relocating assembly to Southeast Asia because of US tariffs, and Ju Teng's asset base was about 79% PRC by non-current assets at end-2025. The group has been monetising PRC land through government resumptions and disposals while building in Vietnam. **Shareholding structure:** It is unusual: a share-award trust holds 29.53% of the equity and a founder trust holds 25.27%. That structure largely determines the outcome of the Lens Technology offer.

Revenue$0.7B
Employees21,000
Market CapN/A
Founded2000
Central, Hong Kong
Ju

Ju Fu Tang Biotech Holdings Co., Ltd

Premium
Information Technology

Ju Fu Tang Biotech is a Hong Kong micro-cap in transition. Its revenue base is still almost entirely a small civil engineering and fit-out subcontracting business, now overlaid with an investment portfolio and an embryonic medical-device trading arm. In FY2026, 94% of revenue (HK$35.4M) came from roads and drainage, structural works, site formation and decoration subcontracting for a highly concentrated client base. One customer contributed 85% of revenue. A new "health technology" segment sold HK$2.1M of medical devices through a newly formed Shenzhen subsidiary. The return to a reported profit of HK$23.3M was driven by HK$27.4M of fair-value gains on Hong Kong-listed equities, not by operations. Operating margins in construction remain near break-even. The 2025 rebranding to a "biotech" name signals management's intent to pivot towards wellness, elderly-care and medical technology serving the Greater Bay Area. That strategy is, however, at an early stage and is not yet resourced at scale. --- ### Company's own description (paraphrased from the FY2026 Annual Report) The Group describes itself as engaged in three activities: (1) civil engineering and construction; (2) health technology and medical-product sales; and (3) investment holding. The Company itself is an investment holding company. The ESG report states that, despite the English name change during the year, the Group's principal business remains that of a civil engineering subcontractor in Hong Kong. Its civil works fall into four categories: **Roads and drainage:** building and improving local roads, carriageways with junction improvements and associated footpaths, planting areas, drains, sewers, water mains and utility diversions. **Structural works:** reinforced concrete structures, including bridges and retaining walls. **Site formation:** excavation and/or filling to form new sites or reach designed formation levels. **Decoration and renovation:** fit-out works including carpentry, marble, plastering, ceiling installation and project-management support. The health technology business sells medical-device products. Revenue is recognised at the point the customer accepts delivery. Management concluded that the Group acts as principal in these sales because it controls inventory before transfer and bears inventory risk. ### Business model and revenue model | Dimension | Characterisation | Evidence | |---|---|---| | Revenue model mix | Project or contract services (94.4% of FY2026 revenue) plus product sales (5.6%). There is no subscription or licensing revenue. | FY2026 AR note 8 | | Pricing | Construction work is priced cost-plus at tender. Mark-ups are lower on larger contracts and adjusted for complexity, uncertainty and competition. Contracts have fixed prices with milestone payments. | FY2026 AR MD&A, note 8 | | Retention | Clients typically withhold 5–10% of contract value as retention for 1–2 years. This sits in contract assets until the defects period ends. | FY2026 AR note 20 | | Recognition | Construction revenue is recognised over time using an output method based on surveys and interim payment applications. Medical-device revenue is recognised at a point in time. | FY2026 AR note 3 | | Value-chain position | Tier-2/3 subcontractor beneath main contractors. Construction waste is handled by the main contractor. Heavy reliance on sub-subcontractors: the largest subcontractor took 58% of subcontracting spend and the top five took 99%. | FY2026 AR ESG and Directors' Report | | Customer types | Main contractors on public and private civil works in Hong Kong. The top five customers have mostly worked with the Group for more than 10 years. Medical-device customers are in the PRC (names not disclosed). | FY2026 AR | | End-markets | Hong Kong public infrastructure and private development (civil); PRC medical-device distribution (health technology); Hong Kong-listed equities (investment). | FY2026 AR | ### Independent characterisation In economic terms, the Group is three things: 1. **A sub-scale, low-margin construction subcontractor.** Gross margin was 2.7% in both FY2025 and FY2026. 2. **A concentrated small-cap equity portfolio.** HK$51.4M at 31 March 2026, equal to 55.5% of total assets and more than the Group's entire equity. Its mark-to-market swings now drive reported earnings. 3. **An optional pivot into health and wellness.** The "Ju Fu Tang" (菊福堂) brand and the health-care (康養) business led by general manager Mr. Cai Chunzhi (蔡淳治) were cited as reasons for the 2025 name change. So far this has produced HK$2.1M of medical-device revenue and a segment loss of HK$19k. The investment case is therefore driven by net asset value and catalysts rather than by earnings power.

Revenue$0.0B
Employees23
Market CapN/A
Founded2015
P.O. Box, Cayman Islands
Jsmart

Jsmart Technologies Group Limited

Premium
Information Technology

### Key identifiers | Field | Detail | Source | |---|---|---| | Legal name | Jsmart Technologies Group Limited | AR 2025-26 | | Chinese secondary name | 金安具身智能科技集團有限公司 (stock short name 金安智能) | AR 2025-26 | | Former names | Daisho Microline Holdings Limited (大昌微綫集團有限公司) | AR 2025-26; HKEX notice 23 Jun 2026 | | Founding / listing | Listed on the HKEX Main Board on 31 January 1990. Aggregators give 1990 as the incorporation year. | irasia.com profile; Finnomena | | Incorporation jurisdiction | Bermuda (exempted company with limited liability) | AR 2025-26 | | Registered office | Victoria Place, 5th Floor, 31 Victoria Street, Hamilton HM 10, Bermuda | AR 2025-26 | | Head office / principal place of business | Suite 22C, 22/F, 228 Electric Road, North Point, Hong Kong (from 15 May 2026). Previously Unit A, 10/F, Fook Hing Industrial Building, 33 Lee Chung Street, Chai Wan. | AR 2025-26; Morningstar | | Exchange / ticker | Stock Exchange of Hong Kong, Main Board; 0567 (00567.HK) | HKEX | | ISIN | BMG2624V1063 | MarketsMojo; user list | | CUSIP | Not publicly disclosed (not applicable to a HKEX-only listing) | — | | Fiscal year end | 31 March | AR 2025-26 | | Employees | 204 at 31 Mar 2026; 226 at 31 Mar 2025. For historical scale: 1,505 at 31 Mar 2007 and 2,001 at 31 Mar 2006. | AR 2025-26; AR 2007 | | Auditor | Prism Hong Kong Limited (Registered Public Interest Entity Auditor) | AR 2025-26 | | Legal advisers | Michael Li & Co. (Hong Kong law); Appleby (Bermuda law) | AR 2025-26 | | Share registrars | Principal: Appleby Global Corporate Services (Bermuda) Ltd. Hong Kong branch: Tricor Investor Services Ltd. | AR 2025-26 | | Shares in issue | 1,613,287,570 ordinary shares of HK$0.10 each. Authorised capital is HK$400 million (4 billion shares). | AR 2025-26; August 2026 monthly return | | Market capitalisation | About HKD 419.5 million at HK$0.260 per share (16 July 2026 quote). Implied check: 1,613.29M shares × 0.26 = 419.5M. A live October 2026 price was not verifiable. | Investing.com | | Website | www.jsmartech.hk (formerly www.irasia.com/listco/hk/daisho) | AR 2025-26 | | Principal bankers | Bank of China; Bank of Communications; China Merchants Bank; Chiyu Banking; Nanyang Commercial Bank; OCBC Bank (HK); CMB Wing Lung Bank | AR 2025-26 | | Metric | FY2024 | FY2025 | FY2026 | |---|---|---|---| | Employees at year end (number) | — | 226 | 204 | | Total staff costs incl. directors (HKD M) | — | 24.5 | 21.9 | Jsmart Technologies Group is a Hong Kong-headquartered, Bermuda-incorporated micro-cap in the middle of an attempted reinvention. Its operating base is two small legacy manufacturing businesses in Guangdong: - printing and packaging, made in Shenzhen; - printed circuit boards (PCBs), made in Huizhou. Together they generated only HK$43.4 million of revenue in FY2026, down from HK$106.5 million in FY2022. The group has been loss-making in each of the last five years. In April 2026 control of the largest stake changed hands. Jsmart Technologies Limited, founded in 2024 by former CITIC Capital and Value Partners private-equity executive Dr. Sun Jingan, bought the 17.36% block. The company was then renamed around an "embodied intelligence" (AI plus robotics) strategy. The new vision so far rests on two things: - a 15.12% associate stake in a Beijing AI-health-management platform; - a newly formed robotics joint subsidiary targeting healthcare, rehabilitation and elderly care. The equity is therefore best viewed as an early-stage, thinly capitalised transformation option, not as an established robotics operator. ### Data discrepancy flag Investing.com describes the company as "a subsidiary of Kingboard Holdings Limited". This is not supported by the FY2026 annual report. Its register of substantial shareholders lists: - Spring Global / Ng Man Chan / Li Mi Lai (26.41% aggregate at 31 March 2026); - Apact Consultancy (6.44%). Kingboard is not listed, and no Kingboard holding of 5% or more appears. The aggregator statement should be treated as erroneous or stale. Investing.com's descriptor of the company as an intelligent-robotics R&D and manufacturing business also overstates current operations. The disclosed revenue is entirely from PCB and printing. --- ### Company's own description (Annual Report 2025-2026, Report of the Directors) The company's principal activity is investment holding. It operates through four reporting segments: 1. **PCB:** manufacturing and trading of printed circuit boards. 2. **Printing Business:** manufacturing and trading of printing and packaging products. 3. **Trading of petroleum and energy products and related business:** dormant, with no revenue since 2019. 4. **Investments holding.** The Chairman's Statement adds a narrative "Smart Healthcare Business Segment". This covers the associate investment in Beijing Weihang Yining and the April 2026 AI-robotics joint subsidiary. As of FY2026, this "segment" generated no consolidated revenue. The associate is equity-accounted. The Chairman frames the strategy as "strategic expansion into AI and robotics industries" to diversify revenue streams. He describes these as high-growth markets the group could not previously reach. ### Independent characterisation In economic substance, Jsmart today is three things: 1. **A sub-scale contract manufacturer of printed and packaging products.** It is customer-concentrated: the top customer accounts for 31% of group sales and the top five for 73% (FY2026). It is exposed to export-oriented consumer demand that customers are diversifying away from China. 2. **A very small PCB maker.** Revenue was about HK$15.7 million in FY2026. Its boards go into: - smart residential buildings; - commercial-building central control systems; - consumer electronics; - (by management's description) cloud computing. It has no disclosed scale or technology advantage. Peers produce boards on volumes several orders of magnitude larger. 3. **A listed shell-like platform with a small investment book.** This includes: - the equity-accounted 15.12% stake in Beijing Weihang Yining, carried at HK$29.8 million, or 32.7% of total assets; - a 40% joint-venture interest in Noricap Fund G.P. Limited, which holds an indirect 0.86% interest in an SFC-licensed cryptocurrency automated-trading-platform operator; - a newly formed robotics subsidiary. ### Business and revenue model | Dimension | Characterisation | Evidence | |---|---|---| | Product vs service | 100% of FY2026 consolidated revenue is from manufactured products: 63.8% printing/packaging and 36.2% PCB (derived) | AR 2025-26 MD&A | | Subscription / licensing | None disclosed | AR 2025-26 | | Revenue recognition | Product sales under HKFRS 15, mainly at a point in time | FY2023/FY2024 results announcements | | Value chain position | Mid-stream converter. Buys paper, inks, copper-clad laminate and chemicals; sells to OEMs and brand owners. | AR 2025-26 ESG climate table | | Customer types | B2B: brand owners and packaging buyers; electronics OEMs (building automation, consumer electronics) | AR 2025-26 | | End-markets | Consumer goods packaging; smart buildings; consumer electronics; cloud/data infrastructure (claimed); NEV and embodied-AI (aspirational) | AR 2025-26 Chairman's Statement | | Customer concentration | Largest customer 31%; top five 73% | AR 2025-26 | | Supplier concentration | Largest supplier 14%; top five 35% | AR 2025-26 | | Currency exposure | RMB, HKD and USD. No hedging derivatives in FY2026. | AR 2025-26 | ### Planned new model (aspirational) Management's stated intent is to: - commercialise AI and intelligent robots in medical treatment, rehabilitation and elderly care, through the joint subsidiary formed on 7 April 2026; - "advance the application of technologies in the embodied intelligence sector" from the PCB base. No revenue model, pricing, product specification, capital budget or timeline for these initiatives has been disclosed. The annual report states the group has no concrete plans for material investments or capital assets acquisitions for the coming 12 months. This sits awkwardly with the rebranding narrative.

RevenueN/A
Employees204
Market CapN/A
Founded1990
Hamilton HM, Bermuda
Joyzyme

Joyzyme Group Limited

Premium
Information Technology

Joyzyme Group is a micro-cap Shenzhen-based medical device and health products company listed on Hong Kong's GEM board. Its legacy and still-dominant franchise is the research, manufacture and sale of in-vitro diagnostic (IVD) reagents for male infertility — a niche in which it holds a portfolio of 32 registered male fertility reagents — supplemented by parasite and Epstein-Barr virus antibody tests and auxiliary reproductive supplies. Revenue has been essentially flat at RMB24–28 million for eight years while losses have persisted every year since at least 2020. Following a change of control in October 2025 to enzyme-technology entrepreneur Dr. Zhou Xunyong, the group is repositioning toward women's health (via the June 2025 Keyue acquisition), Canadian-licensed nutraceuticals (Nutronic brand) and "silver economy" longevity products, under a new name evoking enzyme-based wellness. The investment case is now one of transition: a cash-rich, debt-light but shrinking-demand diagnostics business funding an unproven consumer health pivot. --- ### Company's own description (AR2025 / IR2026) In its notes to the financial statements, the group describes itself as principally engaged in the research and development, manufacturing, marketing and sale of (i) biological reagents and auxiliary reproductive supplies and equipment and (ii) healthcare products and supplements in the PRC. The AR2025 management discussion frames the biological reagents business as continued focus on male fertility IVD reagents, while the healthcare segment is presented as the vehicle for women's health, longevity and nutraceutical expansion. The co-chairman's statement in AR2025 positions the group's mission around the slogan "Fighting for fertility, building better beginnings" and describes a pivot from product supply toward an integrated healthcare service ecosystem. ### Independent characterisation Joyzyme is, in economic substance, two very different businesses held inside a cash shell: 1. **A mature, high-gross-margin specialty IVD reagent maker** (≈78% of H1 2026 revenue) selling semen/seminal plasma biochemical and related reagents to PRC hospital andrology departments, reproductive medicine centres and distributors. Gross margins on this business are high (group margin was 67–68% before the healthcare segment diluted it), but scale is tiny (≈RMB25.5M p.a.) and the end-market is structurally pressured by China's collapsing birth rate (5.63‰ in 2025 versus 6.77‰ in 2024, cited in AR2025 from the National Bureau of Statistics). 2. **An early-stage consumer health business** (≈22% of H1 2026 revenue) comprising Hunan Keyue Biotechnology (women's health supplements with a caregiver-service model, brands Yukunshu and Qinghuiyue) and the relaunched Canadian Nutronic brand (27 Health Canada Natural Health Product licences). This segment is loss-making at the segment-result level (−RMB0.99M in H1 2026) and carries a lower gross margin (≈45% in FY2025). The group holds ≈RMB39M of cash and deposits against equity of ≈RMB49M (June 2026), so cash constitutes roughly 80% of book value; the operating businesses are being funded from this balance while new related-party and money-lender debt has been introduced. ### Business and revenue model | Dimension | Characterisation | |---|---| | Revenue model mix | ~100% product sales (reagents, consumables, equipment, supplements). No subscription, licensing or recurring service revenue disclosed. Keyue's planned "caregiver service and experience" model is aspirational; no service revenue line is reported | | Value chain position | Upstream manufacturer (reagents produced in Shenzhen); healthcare products appear to be a mix of own-brand and sourced/contract-manufactured goods (manufacturing arrangements not disclosed) | | Customer types | Hospitals, reproductive/andrology clinics and distributors for IVD (per prospectus framing and segment description); wholesale and e-commerce channels for healthcare products. One healthcare customer ("Customer A") contributed RMB2.27M (13.7% of group revenue) in H1 2026 | | Credit terms | 30–180 days for certain long-term customers; deposits required from others (IR2026 note 14) | | End-markets | PRC male infertility diagnostics; PRC infectious disease serology (liver fluke/parasite, EBV); PRC assisted reproduction consumables; PRC women's health supplements; Canadian/North American natural health products (early) | | Geography | 100% of revenue from the PRC (FY2025, H1 2026) |

Revenue$0.0B
Employees98
Market CapN/A
Founded2017
P.O. Box, Cayman Islands
Joyas

Joyas International Holdings Limited

Premium
Information Technology

Joyas International Holdings is a Bermuda-incorporated, Hong Kong-managed shell-like holding company. Its only revenue-producing asset is a 70% stake in CCIG Financial Services Limited, a licensed Hong Kong money lender. The loan book is about HK$16.5 million gross, spread across six borrowers. Interest and loan-referral income total roughly HK$3.5 million a year (FY2025). The company was originally an SGX Mainboard IPO in 2008 as a designer and manufacturer of metal gift products, jewellery and packaging. Since about 2015 it has passed through a failed nickel-ore trading venture, a short forex-investment holding, and an announced but dormant fintech/blockchain joint venture. In October 2026 it said that venture would be repurposed into renewable-energy engineering services. The lending subsidiary is profitable at the operating level. However, the costs of being listed on Catalist (professional and audit fees of about HK$2.3 million a year) consume nearly all of its earnings, so the group reports persistent small losses. Two holders control about 63% of the shares. --- ### Company's own description (AR2025, paraphrased) In AR2025, the company describes the Group as engaged principally in financing and related business during FY2025. All revenue comes from loan interest and loan-referral services in the PRC (including Hong Kong). The Company itself is an investment holding company, and its subsidiaries provide financing. Management describes itself as "exploring and evaluating" opportunities in artificial intelligence, fintech and blockchain; the 1H2026 announcement adds renewable energy to that list. It also says it is negotiating with several potential acquisition or cooperation targets, with no definitive agreement reached. ### Independent characterisation | Revenue line, FY2025 | HK$'000 | Share of revenue | |---|---|---| | Loan interest income | 2,906 | 83.0% | | Loan referral service fees | 595 | 17.0% | | Borrower type | Number | Principal (HK$ million) | Rate | |---|---|---|---| | BVI investment companies | 2 | 5.0 each | 12% | | Hong Kong individuals | 4 | 2.5 | 12% | | — | — | 3.0 | 36% | | — | — | 1.0 | 30% | | — | — | 0.07 | 24% | Economically, Joyas is a micro-scale private-credit vehicle inside a listed shell. Its main features: **Business model:** CCIG Financial Services Limited lends under a Hong Kong Money Lenders Ordinance licence. It funds the book with: - shareholders' equity (about HK$9.6 million at 30 Jun 2026); and - high-cost third-party borrowings, repayable on demand at 12–18% a year (HK$7.3 million at 30 Jun 2026). Until FY2025 it also used a HK$10 million bank overdraft secured by an equal fixed deposit. That overdraft was effectively a balance-sheet gross-up and was repaid in FY2025. **Revenue model:** 100% financial services, as follows: There is no product, subscription or licensing revenue. **Value-chain position:** Direct balance-sheet lender with no securitisation or syndication. The referral fees suggest it also earns origination or introduction income on loans placed elsewhere. The counterparty is not disclosed. **Customer types:** Six borrowers at 31 Dec 2025: The three customers above 10% of revenue generated 65% of FY2025 revenue (HK$2.275 million of HK$3.501 million). **End-markets:** Hong Kong private and corporate credit. There is no retail franchise, no branch network and no brand presence. **Structural reality:** The operating subsidiary earned a profit of HK$182k in FY2025 (HK$324k in FY2024). Group overhead turned this into a consolidated loss of HK$641k. Professional fees alone were HK$1.664 million, or 47.5% of revenue (AR2025 Note 13).

Revenue$0.0B
Employees7
Market CapN/A
Founded2006
Bermuda
JotunA/S

Jotun A/S

Premium
Information Technology

Jotun is a family-controlled Norwegian paints and coatings group that has quietly built one of the most profitable franchises in the global coatings industry. With FY2025 consolidated operating revenue of NOK 34.3 billion and an operating margin of 20.6%, it ranks tenth worldwide by coatings sales but sits near the top of the peer group on profitability and returns (ROCE 33.9%). The business spans four segments — Decorative Paints, Marine, Protective and Powder Coatings — organised in a matrix across five regions. Its defining strategic traits are organic growth, segment diversity, early entry into emerging markets (Middle East since 1962, South East Asia since 1968, China since 1983) and a premium, service-led positioning. Jotun is the recognised global leader in marine coatings, a strong number-one or number-two decorative brand across the Gulf and South East Asia, and a leading supplier of passive fire protection and offshore-wind coatings. Some 93% of revenue is generated outside Norway. --- ### What the company does — company's own description In its FY2025 annual report, Jotun describes its business activities as the development, production, marketing and sale of paints and coatings systems, solutions and services for the treatment, protection and beautification of assets. Its corporate mission is "Jotun Protects Property". The group organises its offering into two business areas — Decorative Paints and Performance Coatings — with Performance Coatings comprising Marine, Protective and Powder Coatings, giving four reporting segments. Sales are run through five regions: Europe and Central Asia (ECA), Middle East, India and Africa (MEIA), North East Asia (NEA), South East Asia and Pacific (SEAP) and Americas (AM). (Source: Jotun Annual Report 2025, Board of Directors' report, section 1.) The company characterises its business model as leveraging local knowledge and competence in each market, supported by regional hubs, within a matrix organisation that grants regional and local operations a significant degree of autonomy. Its stated strategy rests on three elements: organic growth, segment diversity and a differentiated approach. (Source: Annual Report 2025, Sustainability statements – Strategy and business model.) ### Independent characterisation Jotun is best understood as a vertically integrated formulator and manufacturer of specialty coatings that captures value through brand, formulation know-how, technical service and distribution, rather than through raw-material ownership. It buys resins, pigments (notably titanium dioxide), solvents, additives and packaging from chemical suppliers; formulates and produces in 40 plants in 25 countries; and sells through three principal channels: 1. **Dealer / retail channel (Decorative, increasingly Protective):** a network of roughly 10,000 dealers worldwide, supported by in-store colour tinting (Jotun Multicolor), the new Jotun Shop Concept (more than 1,000 dealers converted by end-2025), colour marketing (Global Colour Trends) and digital ordering tools. 2. **Direct project and specification sales (Protective, Powder, Decorative projects):** specification-driven sales to EPC contractors, energy majors, architects, fabricators and applicators, backed by more than 1,200 Coatings Advisors in its Technical Sales and Service (TSS) organisation, which Jotun describes as the largest in the industry. 3. **Direct key-account sales (Marine):** to shipyards (newbuilding), shipowners and managers (drydock maintenance) and on-board supply (SeaStock), increasingly bundled with performance guarantees, digital hull-monitoring services and robotic hull cleaning. ### Revenue model mix | Revenue type | Description | Estimated weight | Disclosure status | |---|---|---|---| | Product sales | Paints, coatings, powders sold per litre/kg | Overwhelming majority of revenue | Mix not quantified by Jotun | | Bundled performance solutions | Hull Performance Solutions (HPS 2.0) with performance guarantees; system specifications | Embedded within Marine product revenue | Not separately disclosed | | Services (technical and digital) | Coatings advisory and inspection (TSS), AssetKeeper corrosion assessments, HullKeeper hull monitoring, Jotun Voyager, efficiency analysis for powder applicators | Small; largely a sales enabler rather than a standalone revenue line | Not separately disclosed | | Equipment-enabled solutions | Hull Skating Solutions (robotic proactive hull cleaning), commercially launched in 2025 | Early stage | Not separately disclosed | | Licensing / royalties | No material licensing revenue disclosed | Not material | Not disclosed | | Subscription | Digital services may be subscription-like, but no subscription revenue reported | Not material | Not disclosed | ### Value chain position Jotun sits in the middle of the chemicals value chain: downstream of commodity and specialty chemical producers, upstream of applicators, painters, shipyards and asset owners. Its own GHG inventory illustrates how upstream-heavy the cost base is: purchased goods and services (mainly raw materials) account for about 71% of total market-based emissions (3.29 million tCO2e of 4.63 million tCO2e in 2025), and raw materials alone represent around 60% of its emissions footprint. (Source: Annual Report 2025, Climate change mitigation.) ### Customer types and end-markets | Segment | Customer types | End-markets served | |---|---|---| | Decorative Paints | Homeowners, professional painters, contractors, developers, interior designers, public-sector building owners; served directly and via dealers | Residential new-build and repaint, commercial real estate, public buildings and infrastructure | | Marine Coatings | Shipyards, shipowners, ship managers, yacht builders and owners | Newbuilding, drydock maintenance, on-board maintenance (SeaStock), cargo tanks and holds, megayachts and leisure yachts | | Protective Coatings | EPC contractors, fabricators, energy companies, infrastructure owners, dealers | Offshore and onshore oil and gas, power generation, offshore and onshore wind, infrastructure, data centres (intumescent fire protection), industrial facilities | | Powder Coatings | Applicators, OEMs, architects, fabricators | Architectural building components and facades, general industry, pipelines, automotive and EV batteries, appliances, furniture, solar and electrical equipment |

Revenue$3.3B
Employees10,933
Market CapN/A
Founded1926
Sandefjord, Norway
Jisheng

Jisheng Group Holdings Limited

Premium
Information Technology

Jisheng Group Holdings is a micro-cap, GEM-listed industrial holding company. Its only operating business is a contract metal-casting operation based in Huizhou, Guangdong. It designs, develops, manufactures and sells cast components for pumps, valves, filters and food machinery, made from stainless steel, carbon steel, bronze and grey iron. Customers are mainly German manufacturers of flow-control devices and industrial machinery, with smaller customers in mainland China and the United States. Annual revenue is about HK$45–55 million, the group employs about 95 people, and it has reported a loss in every year reviewed. Since 2019 it has tried and abandoned several diversifications: financial printing (2020–2023), cultural-media joint ventures (2023–2024), and now a proposed move into cassava-starch supply-chain trading. The balance sheet is thin, with total equity of HK$14.5m at June 2026. The auditor has flagged a going-concern uncertainty, and the company depends on its chairman's financial support and on new borrowings. The investment case is a restructuring and optionality story, not a fundamentals story. --- ### Company's own description (paraphrased from FY2025 annual results and 2026 Interim Report) The company says it is an investment holding company. Through its subsidiaries it designs, develops, manufactures and sells cast metal products. Some products are made in its own facilities, located mainly in the PRC, and some are sourced from outside suppliers. It groups its products into four categories: (a) pump components, (b) valve components, (c) filter components and (d) food machinery components. The materials are stainless steel, carbon steel, bronze and/or grey iron. It names Germany as its largest market, with further customers in mainland China and the United States. Its principal customers are suppliers of flow-control devices, electromechanical equipment and industrial machinery and equipment. Management describes product quality and tailor-made production as the basis of its long-term customer relationships. ### Independent characterisation Jisheng is a small build-to-print contract foundry and component trader at the lower tier of the industrial-equipment value chain. **Revenue model:** About 100% product sales. Revenue is recognised at a point in time under HKFRS 15 as "sales of cast metal products". There is no service, subscription or licensing revenue. **Value-chain position:** Tier-2/Tier-3 component supplier. The group buys metal inputs from distributors of established metal manufacturers, most of which have distribution points in Guangdong near the Huizhou plant. It casts and machines or finishes parts to customer specification and exports them, mainly to Germany. A surcharge mechanism lets it pass through part of any raw-material and EUR/RMB or EUR/USD currency moves. **Hybrid make/buy:** The filings say products are either sourced externally or made in-house. This means part of revenue is trading margin rather than value added in its own factory, which helps explain its low fixed-asset base (plant and equipment of only HK$1.4m at FY2025). **Customer types:** Original equipment manufacturers (OEMs) and system suppliers in flow control (pumps, valves, filtration), food processing machinery and general industrial equipment. **Concentration:** Three customers made up HK$15.0m, or 52.8%, of H1 2026 revenue (HK$7.6m, HK$5.2m and HK$2.2m). In H1 2025 the same three made up HK$26.9m, or 50.4%. Source: 2026 Interim Report, note 4. **End-markets:** European (chiefly German) industrial capital goods, water and wastewater, process industries and food processing. Demand is cyclical and tied to European industrial capex. **Emerging business (announced, not yet operating):** The company plans to become an integrated supply-chain participant in cassava starch across the PRC and Southeast Asia, covering procurement, inventory and pricing. Management talks about moving from facilitator to principal. No starch revenue had been reported as of 30 June 2026.

Revenue$0.0B
Employees95
Market Cap$0.0B
Founded2003
Kowloon, Hong Kong
Jinhui

Jinhui Holdings Company Limited

Premium
Information Technology

Jinhui Holdings is a family-controlled Hong Kong investment holding company. Its economic value comes almost entirely from its roughly 55.69% stake in Jinhui Shipping and Transportation, an Oslo-listed owner-operator of geared and gearless dry bulk carriers. The fleet stood at 21 vessels and about 1.68 million dwt at 30 June 2026. Holdings consolidates Jinhui Shipping in full, and 100% of reported revenue is chartering freight and hire income. Alongside the shipping stake, Holdings owns a portfolio of Hong Kong investment properties, listed equities, investment funds and a minority co-investment in a Shanghai office tower. The group has spent 2024–2026 on aggressive fleet renewal. It sold older Supramaxes, bought its first Capesizes, and built a 12-vessel Ultramax newbuilding orderbook for delivery in 2026–2030. Its strengths are low cost, conservative gearing and family-controlled decision-making. It is a small, cyclical, illiquid and thinly covered holding company. The shares trade at roughly 0.2× attributable book value, in line with the classic Hong Kong holding-company discount. --- ### Company's own description The FY2024 results announcement says the group runs its worldwide shipping activities through Jinhui Shipping, about 55.69% owned and listed on Oslo Børs. Group revenue is described as chartering freight and hire income from owned and chartered-in vessels. The 2021 Annual Report gives more history. Shipping began in the mid-1980s, mainly as chartering of dry bulk carriers. The group diversified into trading and other businesses from 1992. A June 1994 reorganisation made Jinhui Shipping the immediate holding company of the shipping group, and it was later listed in Oslo to attract international interest. The company also describes itself as running a detailed and complex shipping operation that links suppliers with end users. It decides between operating vessels itself and chartering them out to other operators according to which is expected to bring the higher economic benefit. ### Independent characterisation Jinhui Holdings is best understood as a two-layer structure: 1. **Operating layer: Jinhui Shipping (JIN).** JIN is a tonnage provider in dry bulk. It owns ships, and charters ships in, and then employs them on time charters, mostly period time charters, with a residual spot exposure. Its customers are commodity traders, operators and end-users moving iron ore, coal, grains, steel products, cement, fertilisers, minerals and other bulk cargoes. It is not a liner or logistics business. It earns daily hire (time charter equivalent, or TCE) and bears vessel running costs, depreciation and financing. 2. **Holding layer: Jinhui Holdings (0137).** Holdings owns 55.69% of JIN. Directly or through other subsidiaries, it also holds: - Hong Kong investment properties: HK$273.5 million fair value at 31 Dec 2024, mostly office premises and car parks in a central business district. - Listed equity securities and funds: HK$166.7 million FVTPL portfolio at 31 Dec 2024. - An unlisted co-investment in Tower A, One Financial Street Center, Jing'an CBD, Shanghai. This was a US$10 million commitment in 2018, carried at about US$4.9 million at end-2024. - A related shareholder loan of HK$12.3 million. - Club debentures. ### Revenue model mix | Revenue type | Share of FY2024 revenue | Comment | |---|---|---| | Time-charter hire income (operating lease component) | ~83% | Accounted for under HKFRS 16 as operating lease income, recognised straight-line (FY2024 note 2) | | Non-lease crewing-service component embedded in hire | ~17% | HK$216.0m of the HK$1,239.4m in FY2024 (HK$237.6m of HK$638.6m in FY2023) | | Product sales | 0% | None | | Subscription / licensing | 0% | None | Outside revenue, "other operating income" adds investment-property rent (HK$6.3m in FY2024), dividend income (HK$10.0m), other shipping operating income (HK$37.0m), fair-value gains on securities and occasional litigation settlements. ### Value-chain position Jinhui sits in the asset-ownership and tonnage-provision segment of the dry bulk value chain: **Upstream:** shipyards (Jiangsu Hantong, Jiangmen Nanyang, New Dayang), ship-finance banks and lessors, and crew managers. **Downstream:** charterers, meaning operators, traders and end-users. It does not do commercial cargo booking at scale the way an operator such as Oldendorff or Pacific Basin's operating arm does. That limits its margin capture to the time-charter spread. ### End-markets and trade exposure On the Q2 2026 earnings call, management said that in H1 2026 about 42% of chartering revenue came from cargoes loaded in China. Australia accounted for 23%, Africa 16%, Asia excluding China 12% and North America 7%. China was the discharge region for 54% of cargoes. Demand therefore depends heavily on Chinese steel, construction, power generation and agricultural imports, and on Australian and African mineral exports.

Revenue$0.2B
Employees74
Market Cap$0.0B
Founded1991
Hong Kong
Jinhai

Jinhai Medical Technology Limited

Premium
Information Technology

Jinhai Medical Technology is a small-cap, Hong Kong-listed holding company in the late stage of a pivot from a Singapore construction-labour supplier into a Shanghai-based distributor and solutions provider of minimally invasive surgery (MIS) products. The legacy business, founded in 2006 as Kakiko, supplies foreign construction workers, operates workers' dormitories and provides small IT and construction-ancillary services in Singapore. Since Shanghai real-estate entrepreneur Chen Guobao acquired control in 2019, the group has built a PRC medical-device business that grew from S$0.7 million of revenue in FY2022 to S$30.0 million in FY2025 and S$25.4 million in 1H2026 alone, now 75% of group revenue. Its most visible technology claim is a navigated spinal endoscopy technique co-launched with Medtronic China in late 2025. The group remains loss-making, highly customer-concentrated and thinly margined, yet trades at a market value of roughly HK$22.5 billion, more than 50 times trailing sales. --- ### What the company does The group reports two operating "natures" plus a corporate cost centre. The CODM (the executive directors) reviews revenue by nature and profit or loss for the group as a whole, so the group presents only entity-wide IFRS 8 disclosures: "Products", "Services" and "Others" (FY2025 results, Note 3). 1. **Products (PRC):** provision of minimally invasive surgery solutions and medical products and the related service fee. Revenue is recognised at a point in time. It is earned through Shanghai Jinhai Medical Technology Company Limited (上海今海醫療科技有限公司) and related PRC subsidiaries, including Jinhai Technology Development (Shanghai) Co., Ltd. and, from January 2026, the 51%-owned Jinhai Biomedical Technology (Shanghai) Co., Ltd. 2. **Services (mainly Singapore):** manpower outsourcing and ancillary services to building and construction contractors; workers' dormitory services, accounted for as rental income; IT services (historically to a single customer); and construction ancillary services (warehousing, cleaning and building maintenance). The 2025 Annual Report's Report of the Directors also mentions manpower outsourcing in China, and the FY2025 geographic split shows a small amount of PRC service revenue, but this is immaterial. 3. **Others:** corporate office functions (Hong Kong and holding-company costs, including the large equity-settled share-based payment charges since 2024). ### The company's own description (paraphrased from the latest filings) In the 2025 Annual Report, management says it has reassessed strategic direction and resolved to allocate group resources to MIS solutions, medical products and related services. It frames China's MIS-device market as among the fastest growing globally. The company states it will compete by (a) strengthening R&D, (b) expanding its distribution network, (c) developing new products and (d) promoting resource integration. In the same report, management expects the Singapore labour-dispatch, dormitory and construction-related businesses to be materially affected as the Singapore Government reorients investment priorities from infrastructure towards AI. In the 1H2026 interim announcement it says it will review the market position and prospects of the Singapore manpower business in 2H2026. ### Revenue model and mix | Revenue type (FY2025) | Recognition | S$ '000 | % of total | |---|---|---|---| | Product sales: MIS solutions and medical products and related service fee (PRC) | Point in time | 29964 | 64.7 | | Service: manpower outsourcing and ancillary services | Over time | 12685 | 27.4 | | Rental: dormitory services (Singapore) | Lease income | 2923 | 6.3 | | Service: IT services | Over time | 434 | 0.9 | | Service: construction ancillary services | Over time | 270 | 0.6 | | Total | — | 46276 | 100.0 | Source: FY2025 annual results announcement, Note 3 and MD&A. In 1H2026 the product line rose to S$25.4 million of S$34.0 million (74.7%). The model is therefore now predominantly product sales, with no disclosed subscription or licensing revenue. The product revenue line includes a "related service fee", but the split between hardware/consumable sales and service fees is not publicly disclosed. ### Value-chain position: independent characterisation The financial signature of the medical business points to a distribution and commercialisation model rather than a vertically integrated manufacturer: **Thin product margins:** "Cost of inventories sold" relative to product revenue implies low gross margins: about 5.1% in FY2023 (19,390 vs 20,431), 4.5% in FY2024 (24,768 vs 25,927), 12.7% in FY2025 (26,162 vs 29,964) and 15.4% in 1H2026 (21,519 vs 25,427). This is an analyst approximation; inventory cost may not equal the full cost of product sales. **Minimal R&D:** R&D expenditure was only S$850k in FY2024, S$742k in FY2025 and S$112k in 1H2026, against product revenue in the tens of millions. **Extreme customer concentration:** In FY2024 a single customer ("Customer B") contributed S$24.2 million, 93% of product revenue. In 1H2026 two customers contributed S$25.0 million, 98% of product revenue. These patterns are consistent with sales to a small number of distributors or platform partners rather than to many hospitals directly. **Commercial build-out:** A Chief Marketing Officer (Mr. Ma Chengdong) was appointed on 3 August 2026, with responsibility for marketing strategy, market access, academic promotion, sales and channel operations, and the commercialisation of the group's medical device and equipment products (voluntary announcement, 3 August 2026). **Technology partnership with Medtronic:** In November 2025 the subsidiary co-launched a navigated spinal endoscope technique with Medtronic China's Orthopedics and Neurosurgery Business Group. On 6 November 2025 Jinhai Technology Development (Shanghai) signed a strategic cooperation framework agreement with Medtronic Changzhou Medical Device Co., Ltd. to promote real-time navigation and tracking spinal endoscopy in Chinese clinical practice (AR2025, Chairman's Statement). This positions Jinhai as a clinical-technique and channel partner adjacent to a global OEM. In the Singapore legacy business, Jinhai is a labour intermediary (deploying foreign workers to contractors, paid by deployment hours, with salespeople commissioned on hours deployed) and a landlord of purpose-built workers' accommodation. Those properties are now pledged as security for group borrowings. ### Customer types and end-markets | Business | Customer type | End-market | |---|---|---| | MIS solutions and medical products | Not named. Two customers (A and B) accounted for 55.3% of group revenue in FY2025 and 73.6% in 1H2026 | PRC hospital surgical market (spine and broader MIS); end-users are surgeons and hospitals | | Manpower outsourcing | Building and construction contractors in Singapore | Singapore construction | | Dormitory services | Employers of foreign workers | Singapore foreign-worker accommodation | | IT services | Historically a sole IT customer (FY2022 and FY2023 MD&A) | Not disclosed | | Construction ancillary | Contractors and industrial tenants | Singapore construction and industrial property |

Revenue$0.0B
Employees472
Market Cap$2.9B
Founded2006
Singapore
JinMiFang

Jin Mi Fang Group Holdings Limited

Premium
Information Technology

Jin Mi Fang Group is a micro-capitalisation, GEM-listed holding company. Between 2023 and 2026 it changed from a Hong Kong casual-dining restaurant operator into a mainland-China food-and-liquor distribution platform, a pivot driven by its new controlling shareholder. **Control change:** Mainland liquor entrepreneur Zhou Feng acquired control in October 2023 at HK$0.032 per share. **Exit from Hong Kong:** The group closed all of its Hong Kong restaurants, including franchised Du Hsiao Yueh (度小月) outlets, by late October 2024. **Current revenue base:** In FY2026, 100% of revenue (HK$22.2 million) came from B2B Chinese baijiu supply, OEM-customised liquor and e-commerce food distribution in the PRC. **Portfolio build-out:** It assembled the business through nominal-consideration (RMB1) acquisitions of majority stakes in a Nanjing e-commerce platform operator, a Guizhou liquor maker and a Yunnan Pu'er tea company. **Re-entry plans:** It plans to return to Hong Kong catering through a hotpot joint venture. **Financial position:** The group is loss-making, has negative equity of HK$17.1 million, and its auditor reports a material uncertainty over going concern. It is best characterised as a controlling-shareholder-funded turnaround vehicle with very high concentration, liquidity and governance risk. --- ### Company's own description (paraphrased from FY2026 results) The company describes itself as an investment holding company. Its subsidiaries provide catering and related business, and sales and distribution of food and wine, in Hong Kong and the PRC [S1]. Its wine-supply business covers brand management, customisation, marketing and distribution of premium liquor, with an emphasis on business-to-business sales of Chinese baijiu. The stated ambition is to become a well-known liquor supplier in the PRC. Operationally, the company says it has: - set up a wine supply department; - been developing liquor recipes; and - been negotiating with distilleries to produce customised liquor on an OEM basis [S1]. Since FY2025 it has also distributed food products through an e-commerce platform. That platform was operated by Nanjing Zerui Longxiang Supply Chain Management Co., Ltd., in which the group took a 55% stake in September 2025 [S1][S5]. ### Independent characterisation On the evidence of the filings, Jin Mi Fang is today a thinly staffed (18 employees) trading and distribution intermediary in mainland China. Its income statement has three features that stand out. - **Revenue is entirely PRC goods sales recognised at a point in time.** All HK$22.2 million of FY2026 revenue was recognised this way. There is no subscription, licensing or service revenue [S1]. **Gross margins are trader-like and compressing:** Group gross margin fell from 59.0% (FY2025) to 38.0% (FY2026) after the high-margin Hong Kong restaurants were removed [S1]. The food-and-wine segment's profit margin fell from 46.7% (FY2024) to 18.6% (FY2025) to 5.4% (FY2026) [S1][S2]. **Working capital is extended and largely uncollected:** At 31 March 2026, trade receivables of HK$32.0 million exceeded annual revenue. All of it was aged over 90 days, and credit terms granted run from 90 to 365 days [S1]. The business model therefore rests on extended B2B credit, sourcing via OEM distilleries and related-party ecosystems, and channel distribution through an e-commerce platform the group now controls. It is not a brand-owner model with pricing power. ### Revenue model mix | Revenue model | FY2026 share | Notes | |---|---|---| | Product sales (B2B liquor, OEM customised baijiu, food products via platform) | 100% | All recognised at a point in time [S1] | | Services (catering) | 0% | Hong Kong restaurants ceased late Oct 2024; hotpot JV not yet open [S1][S5] | | Subscription / licensing | 0% | None disclosed | | Financial services (money lending) | 0% revenue | HK money lenders licence held since 2020; interest income booked in other income in prior years (HK$0.2 million FY2024) [S2] | ### Value chain position The group sits in the midstream (brand management, OEM sourcing, wholesale/B2B distribution, platform retail) of the Chinese liquor and packaged-food value chain. Its upstream integration plans are: **Distilling:** the 52% stake in Guizhou Yijinze, a Zunyi-based liquor producer established in 2025 [S5]. **Tea cultivation and processing:** the 52% stake in Xishuangbanna Menghai Longpu Tianxia Tea [S1][S5]. Downstream, it reaches end consumers via the Zerui Longxiang e-commerce platform and, from April–June 2026, six physical baijiu sales outlets in Jiangsu, Zhejiang, Shanghai and Henan [S1]. ### Customer types and end-markets | Dimension | Detail | |---|---| | Customer types | B2B purchasers of Chinese liquor (identities not disclosed); platform consumers for food and lifestyle products; from 2026, walk-in retail at baijiu outlets | | End-markets | PRC baijiu (Chinese liquor); PRC packaged and fresh food e-commerce; PRC tea (Pu'er, black and white tea); Hong Kong casual dining / hotpot (planned) | | Customer concentration | Not quantified in results announcements. The receivables profile (HK$32.0 million all >90 days) implies a small number of large B2B counterparties [S1] |

Revenue$0.0B
Employees18
Market CapN/A
Founded1993
P.O. Box Grand Pavilion, Cayman Islands

Page 104 of 482

1…103104105…482

Page 104 of 482

Go to page
Deloitte logo
Accenture logo
Oracle logo
PWC logo
EY logo
Honeywell logo